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I NTR O D UCTION 
The past 25 yeus have setn a. period of intensive investigation of the 
role of hormones in stimub.dng growth of m:unmary g lands and in the init-
iation and rrWnten2nce of milk secretion. While a numbtt of species differ-
ences in regud to the role of pituitary and ovarian hormones in mammary 
gland growth remain to be expi2ined, great strides have been made in under-
su.nding the growth and function of this tissue. 
Researchers, in recent years, have shifted attendon to a study ofhor-
mone action at the celJ levd. Evidence is besinnins: to appeu that indiC2te5 
hormones rruy pby:m important part in st1ID.u1:anng enzyme systems pres-
ent in mammary epitheliil cells. Thus. resorch in the field of hormone-
enzyme rebtions may provide answers to several questions which have a-
risen eoncerning mechanisms of mammary gl:tnd growth. 
In looking at the mammary gland from the mndpoint of embryology, 
twO ty~ of tissue can be recognized, the epithelial secretory tissue, which is 
of ectOdermal oris-in, and the connC(tive tissue, which is of mesodermal ori-
gin. The connective tissue serves to support the secretory tissue. 
Most rapid growth of the mammuy gland occurs during the first one-
half to two-ihirds of presnancy fo r it is then that the end and side buds 
rapidly ~necrate the Guner of fatty conneCtive tissue. This can be Sttn in 
the rapidity of division and increased numbers of cells in the alveoli. In-
crease in size of the mammary gland during the larter put of pregnancy is 
primarily due to an increase in amount of secretion in the lumen as secre-
tory activity is initiated; however, an increase in the size of the mammary 
gland capihries after mid-term is a conrributing hctor. 
Rapid increase in size and amount of mammary Sttretory tissue during 
pregnancy ruses the question whether part of the ht cells pres~t at the be-
ginning of pregnancy are nor repl:tced. T he hypothesis is suggested that if 
such a replacement takes place, a lirase or esterase may be present in the 
growing gland, aiding the epithelia tissue in its penem.cion into the farry 
pad. 
The mesodermal &try pad, through which the mammary gland sproUts 
advance, consists of loose connective tissue in which fat ceUs are tightly 
packed Fat cdls and connective tissue are hdd together by collagenous and 
dastic fibers which run in all directions around the mass of cells. These fiIxrs 
ue embedded in a jelly-like amorphous material, the ground substance, 
which cements fibers and cells in place. 
Penetration of the mesenchyme by tbe m ammary ducts and the more 
rapid advance through the for midable barrier of the htty pad during preg-
nancy has attracted little comment or speculation from phYSIologists . .R.ather, 
they Sem'1 to have taken this remubble phenomenon for granted. It is sug-
gested (hat some mechanism other than pressure may be responsible for the 
penetration of the gland into the fatty pad. 
Apparently, no one has suggested, heretOfore, the presence of a chemical 
agent 10 cells of the mammary gland which might erode connective tissue 
in front of the growing sproutS and buds, thus making possible their forward 
progress. 
The theory that a chemical agent or enzyme aids in forward growth of 
the mammary gland was given imp<=rus· by (he discovery of spreading factors 
which attack and liquify the ground substance of connective tissue. These 
factors, which enhance the spread of material through the dermis, were 
found (0 break down certain mucopolysaccharides by their hydrolytic u-
cion; thus, they were named mucopolysaccharases. Perhaps the most im-
portam of this group of enzymes is hyaluronidase, which acts on hyaluronic 
acid. 
Preliminary investigacion has shown that a spreading factor is, in faa, 
present in mammary glands of albino ·rats. These data indicate that the 
amount of spreading factor increases during the first part of pregnancy at 
about the same rate as growth of mammary secretOry tissue. Further, de-
dine in amoum of spreading factor agrees with decline in numbers of mitot-
ic figures and leveling off of numbers of epithelial cells found in the alveoli, 
which occurs durin~ the latter part of pregnancy. This study also has shown 
that in ovariectonuzed rats with incact pinlitary and adrenals, production 
of the mammary spreading factor can be stimulated to variable degrees by 
eStrogen alone; although with removal of the adrenals the power of estro-
gen to quse production of the spreading factor was essentially lost. Pro-
gesterone, alone, also was shown to have the power to cause elaboration Ot 
activation of the mammary spreading factor, even in the absence of adrenals. 
However, as in hormone produced mammary gland growth, a combination 
of estrogen and ptogesterone produced the greatest amounts of the spread-
ing factor; amountS which were comparable to thac obtained from normal 
, pregnane rats. -
Since the mammary gland complex consists not only of the growing 
gland, but also of the fatty connective tissue pad, it has been difficult to 
obtain a quantitative measure of the extent of gland growth. If the elabora-
rion or activation of the mammary spreading faCtor during the growth phase 
is related to the extent of growth of epithelial cells, then an estimation of 
the amount of spreading facto r should provide an indication of mammary 
gland growth. 
• 
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Preliminary srudy with the pregnant cae was so encouraging that ob-
servations on the presence of a mammary spreading factor were extended to .. 
other species of experimental animals. 
Further investigation seemed desirable on the role that the pituitary, 
ovarian, and other hormones play in the elaboration or activation of the 
mammary spreading factor. The amounts of spreading factor produced by 
various types, quantities, and lengths of hormone injected also need to be 
related, if possible, to the amount of mammary gland growth. 
While chemistry of the mammary gland spreading factor was not sru-
died extensively, some of its general properties were investigated. 
, 
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PREVIOUS WORK 
I. Spreading Factors 
, 
Discovery of diffusing or spreading factors was first made by Duran-
Reynals in 1928, when he found that a testicular extract increased the in-
fecting power of vaccine viruses. The following ynr, he confirmed this o~ 
servation (Duf2Il-Reynals, 1929). McClean (19;0) also reported that testi-
cular extracts increased dermal permeability to vaccines. A number of in-
vestigations followed which revealed that certain bacteria (Duran.Reynals, 
1933; and Mcdean, 1936), snake venoms (Duran-Reynals, 1939) and leach 
extractS (Claude, 1937) also contained spreading factors. Later, the occur-
rence of spreading factor in extracts of spleen and eye from animal bodies 
was reported (Meyer tt at. , 1940) . 
At about the same time, chemical investigations dealing with isolation 
and characterization of hyaluronic acid were undertaken. After hyaluronic 
acid was definitely isolated and characterized, it was demonstrated that cer-
tain bacteria hydrolyzed this compound with the liberation of reducing 
sugars (Meyertt al. , 1936, 1937a, and 1937b). 
Investigations culminating in reports by Chain and Duthie (1939 and 
1940) showed that a large numbe-r of the spreading factors were an enzyme, 
hyaluronidase, which has for its substrate the mucopolysaccharide, hyalu-
ronic acid. This acid is prescot in the ground subseance of connecdve tissue 
(McClean, 1933; and Duran.Reynals, 1936). 
Chemistry and Methods of ASSllY for H yaluronidase and its Sub-
strates.It is now fairly cercain that hyaluronidase represents a complex of 
several enzymes which brings about enzymatic degradation of hyalutonic 
acid in several steps. Investigations by Madinaveitia and Quibell (1940), 
and East tt aJ. (1941), have shown that glucosidic linkages were nOt opened 
during the short interval of depolymerizarion. Meyer tt at. (1941) found the 
pH activity curve for enzymatic hydrolysis showed tWO peaks, at 4.4 and 
5.8. Further, they demonstrated that a testiculu enzyme produced only 65 
percent hydrolysis of the $ubsuate while incubation of the digest with 
pneumococus enzyme completed the reaction. Hahn (1945 ) founa evidence 
for the existence of a hyaluronidase complex. 
Princiral substrate of hyaluronidase hyaluronic acid, is a straight chain 
polymer 0 high molecular weight, composed ofN-acetylglucosamine and 
glucuronic acid in which both glucosidi linkages are of the 13 configura-
tion (Meyer and Palmer, 1935). While it originaUy had been assumed that 
the end products of testicular enzyme action were disacchuides and those 
of crude testicular and baCterial enzyme action were monosaccharides 
(Meyer,l947), it now has been shown (Hahn, 1947, and Meyertt al. 1952) 
that the end product of hyaluronidase action is a disaccharide and that the 
monosaccharides are produced by g -glucwonidase which is a conraminant. 
The exaCt strucrure of hyaluronic acid still has not been established (Kaye 
and Stacey, 1950; and J eanloz and Forchielli, 19~1). 
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Several in vitro methods of hyaluronidase assay have been perfected. 
One of the earliest was the mucin dot prevention method described by Mc-
Clean (1943). This involves the degradation of dot produced by the addi-
tion of proteio to a solution of hyaluronic acid. T his method is limited in 
application by virtue of its inaccuracy. One of the mOSt commonly used 
assay procedures is the viscosimecric method which is based on discovery 
that the decrease in viscosity is inversly proportional to enzyme concentra-
tioo. Meyer and Palmer (1936) first deveJo~d this method. Modifications 
have been made by Madinavdda and Q uibell (1940), Mcdean and H ale 
(1941), and H aas (1946). 
The turbidity reduction method h:1s recently acquired the mOSt wide-
spread usage. Based on original observations of Kass and Seastone (1944), 
in which it was shown that native hyaluronidate loses ies turbidity during 
depolymerizacion, this method has since been modified by l eonard eJ ai. 
(1946), Dorfman and Ort (1948), W arren et at. (1948), and Tolksdorf et ai. 
(1949). T his method has the advantage of using only small amounts of the 
substrate but, as the units of enzyme are defined in cerms of the assay meth-
od, it suffers from the same difficul ty that made the viscosimetric method 
of assay hard to evaluate. 
" H yaluronidate-Inactive" Sp readin g FaCto rs, their Possible 
Modes o f Action and Assay. In addition to hyaluronidase, chere are many 
ocher spreading factors. Some of these spreading factors may act in conjunc-
tion with hyaluronidase, while others are independent of it. Materials that 
have been found to give dermal spreading, but have no effect in vitro upon 
the substrate hyaluronidate include: peptones (Aylward, 1937, and D unn-
Reynals, 1942); lecithins (Aylward, 1937, and Duran-Reynals, 1942); kalli-
kreins (Christensen, 1938, and Madenaveitia, 1939); extracts from certain 
organs (Claude and Duran-Reynals, 1934, Boyland and McClean, 1935, and 
D uran·Reynals, 1942); human urine fractions (Christensen, 1938); factors 
in venoms (Madinaveitia, 1939; and D uran-Reynals, 1942); and bacteria 
(Blundell, 1942; Burnet and Stone, 1948a and 1948b; and Gar:lOfi, 1933. 
In 1950, Elliott and Turner demonstrated that a spreading.factor was 
present in mammary glands taken from female albino rats, pregnant from 
3 to 18 days. Conceocration of the spreading factor was found to increase 
until about the twelfth day when a gradual d~cline began. Glands from 
normal male and female rats failed to exhibit any spreading effect. T urbidi-
metric assays of the mammary gland extracts showed the active spreading 
factor did not hydrolyze the substrate hyaluronidate. Tests showed that 
while the spreading factor W:1$ still active after heating to 60°C. for 10 min-
utes, it was inactive after heating to 70°C. for 10 minutes. Further investiga-
tion of (he spreading factor (Elliott and Turner, 1951a) showed the mam-
mary spreading factor had no ability to cause pelvic relaxation in mature fe-
male guinea pigs, unlike the ovarian hormone, relaxin. Experiments con· 
ductea by ElGort and T urner (1951b) gave evidence for elaboration or ac-
, 
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dvation of th~ spreading factor in mammary glands in which growth was 
sdmulat~d by hormon~s. 
Thec~:a.r~ s~v~C2l possibl~ exr.lanations why the~ spr~ading factors ar~ 
hyaluronida~ inactive. One possibility, pointed out by Hadinian 2nd Piri~ 
(1948), is that inst~ad of a single homogenous polysaccharide, hyaluronic 
acid, there may be a f2mily of hyaluronic acids which vary gre2.c1y in particle 
size. Hecbter (1948) stated thar, since the information on d~rmal hyaluroni-
date W2S so severly Iimit~d , it was not unreasonable to consider the possi-
bility th2t a dermal hyaluronidat~ was bound (0 protein or some structural 
e1~ment in the skin. H obby and associat~s (194 1) considered some of the 
spreading agents as acting to liberate "bound" hyalUIonidat~ from the slcin. 
Meyer et ai. (1941 ) also believ~d that c~rra in factors may comain a modified 
form of hyaluronidase which can be activated under in vi1l0 conditions. 
Duran-Reynals (1942). however, has pr~s~O[ed the ide2. that these "hya!-
uronida~-inacrive" spr~ading hctors m2y act on some component of the 
dermis other dun hyaluronidate, possibly chondroicin sulfuric acid, collap, 
or other unidentified constituents. 
ASS2Y Methods for Spreading Factors. As these factors have been 
shown nOt to act in vitro several bio-assay methods have been developed 
by which their pow~r to enhance spreading has been demonstrated. The 
firs t of these is an assay proposed by Bacharch, Chance and M idcileron 
(1940). H ere an amount of substanc~, who~ spreading activity is to be mea-
sured. is injected along with a dye into the slcin of 2 shaved white nbbit and 
(he incrase in bleb size mer a cerWn time is noted. H umphrey (1943) pro-
posed practiC211y the same type of assay using (he guinea pig instead of the 
rabbit. Modifications of these assays used. in measuring the amount of mam-
mary gland spreading factor will be described in detail under the section on 
methods and materi2Is. 
II. Growth of the Ma:mmuy Gland in Diffeunt 
Species During Pregnancy 
Since this investigation involves the possible correlation between the 
amount of mammary gland spreading &.Ctor and growth of mamm2C)' gland 
tissue. A shore review is presented on the mammary growth phase in differ-
ent spe<:ies during pregn2ncy. 
The Albino Rat. Development o f the albino rat mamm2ry gland 
during its twenty-one-d2Y gestation period is generally considered to be 
divided into two partS. Growth of glandular tissue occurs during the first 
12 to 1:5 days, with secretion being initiated slowly and increasing during 
the remainder of pregnancy. Roberts (1921) concluded the gland reached 
its maximum growth in 12 days by showing the 2bsence of boch cell divi-
sion 2Qd incre2Se in number of cells 2bout the 2JvCOJi after this period. He 
further showed that v2cuolization of che cytoplasm, which is indiative of 
secretory 2ctiviry, incre2.sed from the thirteenth day of pregnancy. W eather· 
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ford (1929) also found that th~ amount of epithelial tissue reached its peak 
by mid-pregnancy. . 
Jeffers (193~) noted freguent mitosis of alveolar cells up to the fifteenth 
clay of pregnancy. Reece and Warbrinon (1950), in a similar study, reported 
that mitotic activity in the mammaryl.land was greatest ae 10 days of preg-
nancy. In a rl!l:ent stud:r on nucleic ad conccmf1ltion in the rrummary gland 
during pregnancy an bccacion, Kirkham and Turner (1953) found that 
the desoxypentose nucleic acid (which is supposedly constant for the various 
cells and, therefore, reAects cell numbers) increased markedly to mid-preg-
nancy, but only slightly in the latter part of pregnancy and during lactation. 
In contrase, the pentose nucleic acid (which has been proposed to be closely r 
relared to protein synthesis and, therefore, indicating cellular activity) in-
creased throughout pregnancy and lactation, reaching a maximum value at 
21 to 22 days of lactation. 
The Albino Mouse. The next animal to be employed was the albino 
mouse. This animal has the same period of pregnancy as the rat so it is not 
surprising to find that the periods of mammary gland growth and secretion 
for the twO are apptoximately the same. 
Turner and Gomez (1933) concluded that the lobule-alveolar system 
was pracrically complete by che middle of pregnancy, after which secretion 
of the mammarr epithelial cells started. Cole (1933) described g rowth as 
continuing unti the 12th day of pregnancy; however, he did not mention 
the secretory phase. Bradbury (1932) noted that no marked changes occurred 
in the gland during the first three to four days after pregnancy, indicating >1 
the initial Sclmulus inducing mammary gland g rowth during gestation was 
coincident with zygme implantation. 
The Guinea Pig. The guinea pig was selected as an experimental 
animal to give one species with a longer gestation period. les length of 
pregnancy was reported by Ibsen (1928) as about 68 days, while Nelson 
(1933) reported a range of 64 to 68 days. 
In a study of mammary gland growth during pregnancy, condition of 
the gland at che onset of pregnancy is important, since animals having been 
pregnant show a more advanced stage of mammary development than nulli-
parous animals. This is especially true in the guinea pig where the gestation 
period is long. Growth due co an earlier pregnancy might be confused with 
new growth occurring during the pregnancy under study. 
According ro $rockard and Papanicobou (1917), the normal estrus 
cycle in guinea pigs is approximately 15 to 17 days. Due to the length of 
ovarian hormone action. mammary $land growth during this period should 
be noted separately from that occurnng during pregnancy. Locb and Hessel-
berg (1917a and 1917b) concluded that pregnancy in the guinea pig did not 
induce proliferation of the mammary gland to a much greater degree than 
did the hctoes active during the latter parr of the normal estrus cycle, unac-
companied by pregnancy. Proliferation of the mammary gland during preg-
, 
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nancy became regular only at a period of time which exceeded the duration 
of the normal sexual cycle. 
Turner and Gomez (1933) presented observations obtained from stu-
dies on a series of mammary glands from primiparous female guinea pigs. 
Their earli,est stage, exami~ed at 15 days, sho~ed that the gland~ still con-
sisted mamly of a branchmg duct system With very few alveoh. By the 
twentieth day they found a greatly extended gland with a larger duct system 
and the beginning of a well defined lobule-alveolar system. Both of these 
types of development could be distinguished in the 25-and 30-day animals 
but the lobule-alveolar development was much more advanced. In the 33-
day animal they reported duct growth could no longer be distinguished and 
the alveoli appeared to be formed throughout most of the gland. The 47-day 
stage showea greatly enlarged lobule-alveolar development and upon sec-
tioning the pithelial cells of the alveoli were found to contain a secretion. 
Gradual increase in the diameter of the lumina of the alveoli was noted from 
this stage, but even at 57 days the lumina were not greatly distended with 
secretion. The most advanced stage examined was 64 days, at which time 
they noted chac the alveolar lumina were only slightly larger. 
The Rabbit . Development of the mammary ghnd of the rabbit has 
been described by l ane-Claypan and Starling (1906) Ancel and Bouin 
(1911), Shil (1912), and Hammond and Marshall (1914). All reJX>rted that, 
following conception, growth of the duer system continued, after which the 
lobule.alveolar system was rapidly formed. T hey reported that the first 12 
to 15 days of growth during pregnancy were comparable to the growth re-
sulting fro m pseudo-pregnancy. Most students were of the opinion that 
growth of glandular tissue took place before the mid-point of pregn:mcy, 
following which the secretory activity of the epithelial cells began .. loeb and 
Smith (1936) stated chac they believed growth was completed in 15 to 18 
days, but mitosis was still noted as late as the twemy-fourth day. . 
Summary. W hile there may be some variation, reports on individ-
ual species indicate chat growth of the mammary gland is completed during 
the first half to twa-thirds of pregnancy, Secretion is slowly initiated after 
growth is complete. 
III. Hormonal Control of Mammary Gland Growth 
W ork on hormonal control of mammary gland growth has been cov-
ered in a number of reviews by T urner (1932, 1939 and 1950), Riddle (19-
40), Folley and Malpress (1948) and Folley (1952) . Points of special signifi-
cance bearing on the problem make it necessary for a short review. 
Ovarian Hormones and Mammary Gland Growth. Afrer physio-
logists had discarded the idea of neural control of the mammary gland, the 
the concept of hormonal control gained popularity almost immediately. As 
mammaty gland growth seemed so closely associated with pregnancy, atten-
tion began to focus on transplants of ovary. placenta, and fetus as possible 
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sources of hormones. E:uly attempts at linking these organs to hormonal 
control of the mammary ghnd were only partially successful. It was not 
until easy accurate methods of 2ssay of estrogen and progesterone were dis-
covered t h2C conclusive experimentation was possibfe. The assay methods, 
together with isolation of active preparations of estrogen and progesterone, 
led to a great deal of experimentll.uon on mammary gland growth with 
the~ hormones. Aclministution of estrogen in physiological doses was 
found to cause development of t he mammary duct system ( Laquer, 1928; 
Turner and Schultze, 1931). Injection of like doses of progesterone appar-
ently had no stimubtin$ effect on the mammary gland (Corner. 1930). 
H owever, experiment~mon, following the announcement by Turner and 
Frank (1931) that simultaneous injections of estrogen and progesterone 
produced alveolar as well as duct ,growth , led to the conclusion that while 
the mammary duct system grows directly in response to treatment with 
eSfrogen, the combination of both estro~n and progesterone is necessuy 
for alveolar development. 
Thus, while esuogen and progestrone adminism.tion stimulated the 
lobule·alveolar system to an extent com parable co that observed at mid· 
pregnancy in the normal animal, the amountS employed of progesterone 
alone had no growth promoting effects on the mammary ~land. Apparently, 
the ineffectiveness otprogesterone was in the quantity injected, as Gudner 
.and H ill (1936) w~ able to indua: duct growth with luger amounts of pro-
gesterone. Further, it has been shown by Selye (19403 and 1940b) in rats 
and by H artman and Speert ( 1941) in monkeys that su fficiently large a-
mounts of progestttone will evoke both duct and alveolar growth in castI2te 
animals. Mixner and Turner (1941) reporeed that large quantities of the 
steriod, pre$neninolone, produced alveolar development in castrate female 
mice. Expenments by Mixner and Turner in 1943 revealed that alveoli could 
be developed in ovariectomized, virgin female mice with progesterone 
alone, but about 6 times as much progesterone was required to secure a unit 
of alveolar respon~ as when estrogen was given simuluneously. 
Response of the mammary gland co ovarian hormone treatment is not 
uniform. In the guinea pig (Tumtt and Gomez, 1934a; Lyons and Penehan, 
1936, Nelson, 1937; and Lewis and Turner, 1942) and monkey (Turner and 
Allen. 1933; Gardntt and van W agenen, 1938; and Speen, 1940), it has hero 
shown that estrogen brings about alveolar as well as duct growth. 
In the dog, the exact opposite appears to be the crse. Turntt and Gomez 
(1934b), G2rdntt (1941) and Trentin tI aI. ( 19~2) ru.ve shown that estrogen 
either has no effect on mammary duct growth in do~ or it ca.uses its in-
hibition when given in large qw.nticies. Even growth III the norma1 animal 
varies greatly between species. The mammary gland of the male mouse re-
mains es~nciilly a rudimentary duct system throughout normal life (Turner 
and Gomez, 1933 ), though strain differences are Known to occur. By con-
erast. the normal male rat shows rather extensive mammary gl2nd growth 
(T urner 2nd Schultze, 1931). Invesdg:uions to be discussed later make it 
• 
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appear thac the differences in mammary gland growth observed between 
species may be due to production of ovarian honnones by organs other than 
the ovary or the in viw conversion of similar steroid hormones to proges-
cerone. 
Pituitary and Mammary Gland Growth. Perhaps the most success-
ful rype of experiments proving that the pituitary was involved in mam-
mary gland growth consisted of the implantation of pituitary tissue or the 
adminiscration of pituitary extracts to castrate or hypophysectomized ani-
mals. Following this treatment glands were examined for signs of growth. 
Experiments of chis type by Selye and Collip (1936) , G omez and T urner 
(1937), and Nelson (1938) gave the firsc indication that pituitary prepara-
tions directly stimulate mammary gland growth . Experiments also revealed 
a relationship of the pituitary co the estrogen effect on mam mary gland 
growth. ReportS by Nelson (1938), Nathanson et at. (1939), and Astwood 
(1941) indicated that animals treated with estrogen, in addition to pituitary 
extractS, showed better mammary gland growth thAn animals where the pi-
tuitary preparations were administered alone. Furtber experiments along 
this line by Gomez and T urner (1938), Lewis et al. (1939), and Reece ana 
leonard (1939) provided additional evidence for the theory that an anterior 
pituitary faCtor was involved in the induction of mammary gland growth. 
Examination of the mammary glands for signs of g rowth follo wing 
treatment of hypophysectomized animals with estrogen and progesterone 
was another type of experiment frequently cried. Thesc experiments general-
ly supported the theory of the importance of the pituitary and subordinate 
roles of the ovarian hormones. A few research workers reported some mam-
mary gland growth could be obcained in hypophysectomized animals with 
ovarian hormones (R uinen, 1932; de J ongb , 1933; Freud and de J ongb, 
1935; and Asdell and Seidenstein, 1935), while ochers found slight or no 
mammary gland development on treatment of hypophysectomized animals 
with estrogen and progesterone (Selye, et al. , 1935; Rero= et aI., 1936; Gomez 
and T urner, 1936 and 1937; Selye, 1940; and Reece and Leonard, 1941) . 
A third group found th at in the absence of the pituitary, animals re-
sponded to treatment with ovarian hormones by ei ther limited growth or 
growth when the animals were created shordy after hypophyseaom y (Nel-
son, 1936; Leona.rd, 1943 ; and Smithcors and Leonard, 1943). 
Differ~nces in r~sults have been explained partially on th e basis of in-
complete removal of the pituitary. 
Experiments by G omez tt at. (1937) showed that after complete hy-
pophysectomy, estrogen h ad no effect on mammary gland growth; however, 
if as little as 2 percent of the pituitary remained in the animal, mammary 
gland growth response was fair. T herefore, interpretation of mammary 
growth responses to ovarian hormone treatment of hypophysectomized 
animals should be considered valid only after careful histological study has 
revealed that no pituitary residue remained in the animal at the termination 
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of (he experiment. Further, removal of the pituitary would seriously de-
press its target endocrine glands. 
The small amount of mammary gland growth interpreted as a response 
to ovarian hormone treatment ofhypophysenomized animals has been at-
tributed to autonomous qualities of the mammary gland. Limited growth 
of the mammary gland may be possible in the same way that reduced func-
don of aclrenals and thyroids is carried on in the absence of the pituitary. 
Investigation has been going on for some time to determine the pitui-
cary factor which is responsible for mammary gland growth. Research with 
known pituitary fractions has cencered on the adrenocorricorropic,!fOwth, 
and lactogenic hormones as possible mammogens. Gardner an White 
(1942) reponed thar injection of a pituirary extract having marked adreno-
conicorropic aaiviry gave some mammary shnd growrh wben injeaed with 
estrogen Into hypophysectomized male mlee. Nathanson et al. (1939) and 
Reece and leonard (1941 ) reporced mammary gland growth in response 
to treatment of hypophysectomized animals with esrrogen and pituitary 
growth hormone. Gardner and White (1941) demonstrated mammary 
gland growth in the hypophysectomized male mouse following injection 
of estrogen and purified lactogenic hormone. 
Gomez (1942) reponed extensive mammary duct growth in castrate 
hypophysectomized guinea pigs following long injection periods with es· 
trogen and purified lactogenic hormone. However, Gomez believed the 
mammary gland growth might have ~n due to contamination of the laao-
genic preparation with another pituitary fraction. Experiments by Mixner 
et at. (1942) indicated that the pituitary factor responsible for mammary 
gland growth was protein in namre and probably separate from rhe gonado-
tropic, thyrorropic,and lactogenic hormones. Lyons (1943) reported that 
purified lactogenic hormone maintained a normal duct system and a few 
alveoli in hypophysectomized female rats and that addition of a crude ad· 
renocorticotropin and growth hormone caused incomplete alveolar develop-
ment. 
A series of investigations completed by Mixner and Turner (1943) led 
briefly to the idea that there were twO mammary gland growth fanors pres· 
ent in the anterior pituitary. Later experiments by 'frentin and Turner 
(1948) brought about a revision of ideas favoring the rheory that one faaor 
affecting mammary gland growth was secreted by the anterior pituitary. 
Further, Trenrin and Turner (1948) showed that estrogen plus purified lacto-
genic preparations produced good mammary gland growth in male mice. 
Lyons et al. (1952) recently reporced that estrone and progesterone together 
with lactogenic and growth hormone injected into castrate hypophysec. 
tomized rats for 7 to 10 days caused mammary alveolar growth. In a second 
paper (Lyons tt aI., 1953), they claimed that addition of thyroxine and cor· 
tisone to the ovarian hormones and pituitary fraaions caused growth, chen 
Iaaation, in the mammary glands of castrate, hypophysectomized rats. 
Separation of the pituitary fraaions is extremely difficult and, while 
the fractions of today are much purer than those obtained in the past, they 
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may still contain sevc=ru componc=ncs as shown by various mc=chods of idc=nti-
fication. Thus, whik it appc=ars chat thc= pituitary fraction rich in thc= lactO-
genic hormonc= is capable of stimulacing growth of thc= mammary gland, the 
fact chat lactogenesis and mamogenesis arc due to the same pituit:ay facror 
has nor been demonstr2ted ( Astwood, 19~3). 
Androgens and Mammary Gland G rowth . In addition to effeCts 
of the ovarian and pituica.ry hormones, it has been known for some time thar 
androgens may playa role in mammary gland growth. Sclye t t ai. ( 1936) 
first reported that testOsterone benzoate caused slight development of mam-
mary glands in immature male and female !2CS. Nelson and Gallagher (19-
36) aho reported that injection of the various andco$ens, including andro-
sterone, producc=d growth of the du~ts and lobules In castrate virgin rars. 
Other rc=pons by McEuen tJ al. (1936), Astwood tt al. (1937), Bottomley 
and Folley (1938), Fo llc=y tl al. (1939), Lewis tlal. ( lx39), Noble (1939), 
Rc=ece and Mixner (1939), Van Heuverswyn tl al. (1939), Forbes (1942), 
and Mixner and Turner (1943) showed that androgen injection in a number 
of species caused some mammary g land growth in castrate animals but had 
no effect on mammary gland growth in hypophysectomizc=d animals. Are-
cc=nt papc=r by De Graff t l ai. (1950) prC=S(:nte=<! c=xperimc=ntal data which lc=d 
them co believe that testosterone, in sufficiently large quantities, was capable 
of stimulating mammary dc=vdopment excc=c=ding that caused by estradiol 
benzoate and progcs[(:rone, but that physiologinl injeCtions of testosceronc= 
wc=rc= without c=ffecc on the mammary gland. 
Adrenal Cortical H ormones and Mammary Gland Growth. The 
adrc=nal is anmher gland which influences mammary gland growth. Van 
Hc=uverswyn tt ai. (1939) noted that desoxyconicosterone stimula.ced mam-
mi:fy duct growth in imm:Hutc= male micc=. It has been shown that desoxy-
corticostc=ronc= will c=vokc= alveoi2r growth of the mammary g land in thc= 
monkey (Spec=rc, 1940), mouse (Mixner and Turnc=r, 1942) and guinc=a pig 
(Nelson tl aJ., 1943). 
Treatment of hypophyS«tomizc=d anima.1s complicate=<! undc=rscanding 
of the adrenals' rok in mammary gland growth, for Gardner (1940) rc=ported 
obtaining mammary growth in. hypophysectomized male mice as a rc=sult 
of creatment with desoxycorticosteronc=. Further, Chamarro (1940) reportc=d 
that injections of desoxycorticosterone acc=tatc= caused alveolar growth in 
hypophysectomized male rats while Nelson (1941) observe=<! mammary de-
velopment in cascr-ate, hypophysc=ctomized nts m:ated with adreno tropin. 
Ex pc=rimc=nts by Leonard and Reece (1942) again pointed out doubts con-
cerning completeness of hypophysectomy in such c=xperiments when they 
found that rats with pituitary rc=sidues showc=d growth of the mammary 
gland in response to desoxycorticosterone acetate injection while completely 
hypophysectomize=<! animals failed to respond to the same treatment. 
A paper by Mixner and Turner (1943) rc=portc=d that dc=soxycorticoster-
one possessed roughly onc=-thitd the activity of progesterone in causing 
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alveolar growth in C2SmltC femaJe mice. Cowie and Folley (1944 and 1947), 
following this up, found little evidence for mammary ghnd regression after 
adrenalectomy. They noted [h:lt anterior pituitary extC1l.CtS were srill cap:abJe 
of producing mammary growth in adrenalectomized rats. Further, Cowie 
and Folley (1947) stated (hu alveolu development in untreated castr:l.re 
r.iH$ may be due to action of progesterone secreted by the adren2.1 cor-
tex. Trentin and Turner (1948) concluded that, in certain species, mam-
mary alveolar response to esu ogen 2Pparcd (0 be dependent upon the 2bili-
ry of estrogen to stimul:ue the adrenal cortex, which, in rurn, secreted ster-
oids either identical with or re~mbling progesterone in ability co synergize 
with estrogen in stimulation of mammary s:land development. 
T hese theories were supported by investigations of Zarrow t t al. ( 19~O), 
who were able to show th at desoxycorticosterone acetate was converted to 
progesterone in the chimpanzee. 
A recent papa- by Smith and Braverman (l93~) reports that, while 
desoxycorticosterone acetate exerted a duct stimulating effect on the m:un-
mary gland in immature castnte ats, it alone or in connection with low 
levels of progesterone had no effea on lobule alveolar growth. A high level 
of desoxycort icosterone acetate, injected together with estradiol, caused 
only slight alveolar proliferation. These :l.Uthors also St:l.ted they believed the 
progesterone-like act ion of desoxycorticosterone acetate might be due, in 
part, to conversion of the adrenal compound to progesterone, since it close-
ly resembles progesterone structurally. 
Relaxin and Mammary Gland Growth. The phenomena of relan-
tion and separation of the pelvic bones during pregn~cy has been known 
for some time (Duncan, ISn). Observation of this rdax:l.Cion has bttn men-
tioned by other investigators, bur Whitley ( 1911) was the nrst to report 
that t he separation of pubic bones was a gradual process. It remained for 
Todd (1923) ~d Karavau. (1926) to describe the ~atomical and histologi-
cal aspeas of relaxation. 
The normal condition of the pubic symphysis in the virgin female in-
volves collagenous ligaments connecting bOnes of the right and left side, 
anterior and posterior to the symphyses. An interpubic d eft is present be-
tween the opposin$ articular surfaces. Amerior and posterior to this deft, 
there is tissue contlnuity between the cart ilaginous ca.ps of the right and 
left p'ubes. The first cha.nge during pregnancy is seen as the articular hyaline 
ca.rrJiage begins to proliferate and a slight separation of the bones is notice-
able. As the interpubic gap continues to widen, IiAaments connecting the 
bones lengthen by prOliferation of cells at the ends. D uring the final few 
days before panuritlon, an intensive process of resorption of the symphys-
ial ends of the pubic bones mes place. I t has been noted also that cell com· 
position of the li$amenrs changes somewha.c during this phase of mitosis. 
Thus, as the medial ends of the bones a.re "ea.!en awa.y," the ga.p widens and 
the ligaments lengthen. In this way, the passage through whIch the ferus 
must crave! during birth is enla.rged. Following parturition, the gap betWeen 
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the p.u?ic bones closes rapidly, but does nOt completely tecum to the virgin 
condmon. 
Hisaw (1926) was able to produce changes in the pelvic ligaments of 
virgin guinea pigs by subcutaneous injection of blood serum from pregnant 
rabbitS and guinea pigs. These changes proved to be identical with those 
observed during normal pregnancy. Hisaw (1929 and 1930) was later able 
to isolate and iaentify the active material as the hormone relaxin. It has 
been shown that relaxin, a non-steroid hormone, is E~esent in the corpus 
luteum (Hisaw tt al., 1925 and 1927) and placenu (H isaw, 1929) dunng 
pregnancy. Studies on the mouse (Gardner, 1936; Hall and Newton, 1946; 
ancfHall, 1947), and guinea pig (Ruth, 1937) have shown that histological 
changes which bring about relaxation during late pregnancy are due to re-
laxin. 
Van der Meer (1950) presented evidence to supporr the idea that con-
nective tissue of the symphysis pubis may be changed in such a way that 
normal or increased muscle tone or static forces in the pelvis cause the re-
laxation. He suggested further that certain histological changes might be 
due to increased capillary or tissue permeability brought about by relaxin, 
the relaxin having an effect on the connective tissue similar to hyaluroni-
dase or spreading hctors. Van der Meer did not test relaxin for itS a.bility 
co change permeability; be did, bowever, test a number of fa. ctors, includ-
ing hyaluronidase, for their ability to cause relaxa.tion. In no case did any 
orthe &'CtOrs cause relaxation. 
In 1945, Hamolsky a.nd Spurow first tested tbe effect of rela.xin on 
mammary gland growth. They found that relaxin, together with estradiol 
benzoa.te a.nd progesterone, gave !>trter growth and lobulation in immature 
castrate female ra.ts than did the estradiol benzoate and progesterone, alone 
or in combina.tion. 
Garrett a.nd Taima$e (1950 a.nd 1953) tested the effeCts of relaxin on 
mammary glands of gumea pigs and rabbits. In guinea pigs, where it bas 
~n shown that estrogen, alone, is capable of producing full lobule-alveoia.r 
growth, they concludeo chat addition of relaxin to estrogen caused a guanti-
utive increase in degree of gla.nd growth. In the rabbit, where both estrogen 
and pro~cerone a.re necessary for lobule-alveolar growth, the addition of 
relaxin to estrogen caused a greacer development of the duct system but nOt 
alveola.r growtn. They believe, therefore, that relaxin actS as a potentiator 
of estrogen in the case of the guinea pig and that it sensitizes che mammary 
gJa.nd oT the rabbit so that the action of estrogen is more wide-sprea.d on 
the duct system. 
A recent investigation by Trentin (1951) gave a.dditional support to 
the idea that relaxin does noc repJa.ce progesterone in mammary develop-
ment in tbe mouse. This auchor found litrle or no increase in the percent-
age of positive mammary alveoJa.r responses in caStrate female mice treated 
with estrogen, progesterone, and relaxin, compa.red to those treated with 
estrogen and progesterone. 
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While it has ~n proven that a number of endocrine glands and hot-
manes affect mammary $Lmd growth, one hypothesis explains the main 
mammary development In the following way. N orma12utonomous secre-
cion which is observed in a number of the: endocrine glands of hypophy-
sectomized animals may account for a part of mammary gland growth ab-
s<:rved in the hypophysectomized animal and may be responsible for the 
increased duct growth following estrogen treatment. Increased duct growth, 
:mribuced to eStrogen treatment of C1Str:lt(: anim:us, may be due also to in· 
creased utilization of an anterior pituitary factor, normally secreted, which 
causes mammuy glmd growth. Increased amounts of this anterior p ituitary 
neeor are believed co be secreted in response to me presence of progesterone. 
Thus, at sexua..l maturity, or when estrogen is administered, the estro-
gen lIctS directly on the mllmmary gland, incrosing the va..scu1uity:and per-
meabi.li ty ofbJood vessels in the fatty pads. The anterior pituitary facto r 
thus reaches t he glands in increasi ng concentration. T he autonomous 
growth caracity of rhe mammary gland is stimulated a..l so by rhe increased 
amount 0 nutrients supplied by the blood. As a result, the duct system is 
stimulated to g rowth. During pregnancy or when progesterone is given, 
increased senerion of an anterior pituituy factor in response to progeste-
rone brings about a rapid extension of the ducts and alveolar growth of the 
mammary $:Iand. 
VariabIlity in response to the administration of ovarian hormones may 
be accounted for by tne fact that in some species estrogen stimulates the 
production of progesterone by the adrenals. Since adrenal compounds, such 
liS desoxycorticosterone, have ~n shown to be converted to progesterone 
in the animal body, the adrenals may ~ an important source of progesterone 
in the: absence of the corpus luteum. . 
METHODS AND MATERIALS 
1. Assay for the Mammary Gland 
Spreading FaCtor 
In removing mammary ~lands for assay, animals were skinned, leaving 
the glands attached to the skm. The blood was squeezed out, then the fatty 
pads containing the mammary ~Iands were carefully dissected, free of all 
lymph nodes and other tissue. SInce it was sometimes impossible to assay 
the gl:ands immediately, some were held at _l :5 °C until th lS could be done. 
To excr:act the sproding factor from mammary gl:ands, a 0.1 M sodium 
acetate buffer, p H 6.0, with 0.1:5 M sodium chloride was used. With the 
first experimenta..l animal, the albin? ra~. 2:5 mt of the b.uffer was em,?loved. 
Since this amount of buffer gave a dIlUtion of the spreading factor which fell 
within li mits of the assay method, the amount of buffer use~ to ext~act 
mammary glands of the other animals was kept at the same r:atlO of weIght 
of gland per millil iter of buffer. W eight of the mam~ary gland of the nor-
mal female ra t being approximately 4 grams, the rano 6.2 :5 ml. for 1 gram 
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of manunary tissue was used for the other experimental anima1s. The normal 
albino mouse was found to have a mammary gland weighing about 0.8 
gram so 5 ml. of buffer was used for extraction. 
Guinea pigs had mammary glands averaging 4.5 grams, so 30 ml. of 
buffer was employed. Mammary glands of normal female rabbits varied 
greatly; however, the average weight appeared to be around 28 grams. Thus, 
175 mi. of buffer was used to extract their glands. Mammary glands of the 
three larger animals were homogenized in the Waring blender, while the 
mouse glands were homogenized in a Potter homogenizer. The homogen-
ates were then centrifuged for 20 minutes at 2,000 r.p.m. The aqueous 
layer was then pipened off for assay, avoiding, as far as possible, the inclu-
sion of any fraction of the fat layer which formed on top, or the tissue debris 
which centrifuged to the bottom. 
Mammary gland extracts were diluted ten times with buffer solution 
and 0.2 mI. of the diluted extracts was taken up in a 1 ml. tuberculin syr-
inge, along with 0.1 mL of2 percent T-1824 (Evan Blue) dye. After thor-
oughly mixing, the extract and dye were injected intradermally with a 24-
gauge needle into a shaved white rabbit. Injections produced blebs on the 
rabbit's skin which were measured immediately after injection and 30 min-
utes later. The areas of spread were measured, by length and width, to the 
nearest millimeter. The area of the initial bleb was subtracted from the 
final area to give the net area of spread in millimeters sguared. Practically all 
assays were run in duplicate and the average reported. . 
Making injections with a slow steady pressure on the syringe plunger 
was important to obtain a uniform bleb and to avoid, as much as possible, 
the interference of pressure effects upon the amount of actual spread in the 
rabbit's skin. Age of the rabbit also was extremely important. BeSt results 
were obtained with rabbits weighing between 4 and 6 pounds. Condition 
of the skin in rabbits of this size was most satisfactory. If the rabbits were 
more mature, the skin was tOO tough, while smaller rabbits had thin skins 
which were'easily punctured. It was difficult to get satisfactory results out· 
side the weight range indicated. 
To determine the reproducibility of results by this assay method, sev-
eral checks were made. One rabbi t received 10 injections of buffer and 10 
injections of mammary gland extract from a castrate female rat treated 10 
days with 1 ug. estradiol benzoate and 5 mg. progesterone daily. Areas of 
spread from the buffer ranged from 34.6 CO 59.7 millimeters sguared with 
the average of the 10 being 49.6. Areas of spread from the mammary ex-
tracts ranged from 174.4 to 226.3 millimeters squared with the average of 
the 10 being 204.0. The buffer and mammary gland extracts were preserved 
and, over a period of time, were injected into 10 different rabbits. Potency 
of the mammary gland extract apparently was unchanged. Areas of spread 
from buffer ranged for 34.6 to 59.7 millimeters sguared with an average of 
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44.6. Area of spread from mammary gland extracts ranged from 159.5 to 
226.3 millimeters squared with the average being 192.7 (Table 1). 
TABLE I --VARIABILITY OF AMOUNT OF INDUCED INTRADERMAL SPREADING 
IN THE SAME AND DIFFERENT RABBITS 
Trial No. 
1 
2 
3 
4 , 
6 
7 
8 
• 10 
Aug. 
Rabbit No. 
1 
2 , 
4 , 
6 
7 
6 
• 10 
Aug. 
Assays on Same Rabbit in mm2 
Buffer SOlution 
47.1 
47 .1 
34 .6 
47 .1 
34.6 
59 .7 
47.1 
'47.1 
34.6 
47.1 
44.6 .. 12.3 
Mammary Gland Extracts· 
176.0 
191.7 
192.5 
174.4 
209.0 
226.3 
226.3 
209 .0 
226.3 
209.0 
204.0 .. 25.2 
Assays on 10 Different Rabbits 
Buffer SOlution 
47 .1 
59.7 
47 .1 
34.6 
47.1 
47.1 
59.7 
47.1 
47. 1 
59.7 
49.6 + 12 .8 
Mammary Gland Extract* 
160 .3 
159.5 
226.3 
159 .5 
209.0 
209.0 
176.0 
191. 7 
226.3 
209.0 
192.7 .. 33 .4 
*From castr ate female rat received 1 ug. estradiol benzoate .. 5 mg. 
progesterone dally lor 10 days. 
To obtain a better understanding of the meaning of differences in areas 
of spread from different amounts of spreading factor, several extraCtS were 
assayed at various dilutions. Starting with straight extracts of testis and 
mammary glands from a 13-<1ay pregnant rat, assays were made on dilutions 
of 1 to ~, 1 to 10, 1 to 1~, 1 to 20, 1 to 2~, 1 to 30 and 1 to ~O. It was found 
that higher concentrations, dilution of 1 to 10 or less, produced blebs which 
would not exceed an area larger than 24 x 27 millimeters, indicating that 
this was the upper limit of t he assay. It was the extent to which the ex-
traCtS would spread, regardless of amount of spreading factor they connined. 
As the extracts were diluted in series below a 1 to 10 dilution, the areas of 
spread became progressively sm:a1ler. However, even extracts diluted 1 to ~o 
produced spreading in the rabbit's skin (Table 2) . 
Dilution 
No" 
I - 5 
1 - 10 
1 - 15 
1 - 20 
1 - 25 
1 - 30 
1 - 50 
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TABLE 2 __ EFFECTS OF DILUTION ON THE RESUL TS 
OF SPREADrnO TYPE ASSAYS 
Testes Enract 
336.7 
346.0 
288.8 
252.6 
200.8 
152.5 
107.7 
79 .4 
Mammary Gland Extract* 
337.7 
336.7 
217.7 
168.2 
137.1 
114. 7 
92.5 
82.0 
• Extract from rat pregnant 13 days . 
19 
This method of assay re9uireS'Craming in its use and technique and a 
uniform adherence to a single procedure. Both the age of the rabbies em· 
played and care of injection are important in obtaining consistent results. 
Despite the fact that the method has these disadvamages it is the only one 
available for determinacion of the mammary gland spreading factor. With 
care it is a reliable assay method. 
To add more significance to the method it is suggested cllat future 
assays be made along with a standard of known spreading power, this 
standard preparation to be used as a check on variability of assay results ob-
tained on rabbits of different weights between 4 and 6 pounds. 
II. Methods of IndUCing and D etermining 
Pregnancy 
in-the study of the mammary gland spreading factor during pregnancy, 
nulliparous females of each species were employed. Females were placed 
with males and act of coitus observed in guinea pigs and rabbits. Female 
mice placed overnight with the male were examined early the next morn· 
ing for vaginal plugs to determine whether coitus had occurred. When ehe 
guinea pig is in estrum, the vaginal orifice opens. At this eime the female 
was placed wieh the male. 
Conception was considered to have occurred at the time coitus cook 
place. The number of days the animal was reported pregnant started ae that 
time. Animals were checked to see if they would take the male the next 
time they were due to come in estrus. If coitus occurred again, the time for 
ehe stare of pregnancy was reset. The male was placed with the female at 
each calculated estrus period until she no longer accepted service. 
Stage of pregnancy in the rat was determined by examination of the 
fetuses. Experimental feruses were compared in size and length to a series of 
fetuses from rats of predetermined lengths of pregnancy. 
Definite pregnancy was established in the other species by examining 
for fetuses at the time the mammary glands were removed. In the majority 
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of cases, anim21s were pregnant ; those which were nor were used as non-
pregnant control s. 
HI. Methods of Castration 2nd Injection 
in Experimental Animals 
Male 2nd female Wisea! rats from the University of Missouri Colony 
were employed as one experimental animal and female albino mice from 
the White Rose Mousery at Billings, Mo., were used as the other. Females 
of both species wefe castrated by removal of the ovaries through a venrnl 
midline incision. Testes of the male ratS were removed. through an incision 
in each scro tum. Following C2stration, a lO-day resting period was allowed 
for anim:als to recover from (he shock of opeflltion and (or effects of naNnl 
gonadal hormones to wear off. 
If only ustrne animals were to be used, treatment was started on the 
eleventh day. In seJeaed experiments, C2srrate·adrenalectornized t2tS were 
used. Castrare animals were adrenalectomized for these experiments on the 
eleventh day following castr2tion and t~tment was started about five days 
following the last operation. The castrate-adrenalectomized animals were 
maintained on 1 percent sodium chloride in the drinking water. 
Trea.cmems involved daily injections of a number of hormones, general· 
ly for a period of 10 days. A number of experiments were carried on which 
called for longer periods of in jection. Injections were made subcutaneously 
over the shoulder and back, crying as far as possible (0 keep skin irtitation 
at a minimum. The day following the last injection, animals were sacrificed 
and mammary glands removed as previously described. 
The estradiol benzoate and progesterone used in the treacmenc were 
dissolved in olive oil. T he testosterone used was dissolved in 60 percent 
alcohol. Relaxin was already in solution and was used as received. Pituitary 
extracts and whole pituitaries were dissolved or suspended in distilled water. 
All of the materials used to take up the hormones were assayed for theif 
:lbility to cause production of the mammary gland spreading factor. In no 
case did the mammary glands from CaStrace female racs injected with olive 
oil, alcohol, or distilled water give any indication of the presence of the 
spreading factor (Table 3). 
TABLE 3--EFFECTS OF HORMONE SOLVENTS ON THE AMOUNT OF MAMMARY 
GLAND SPREADING FACTOR IN RATS 
M.ammary Extractll f rom 
Castrate Rats Treated with· 
0.2 ml Olive Oil 
0.2 ml 60% Alcohol 
0.2 DlstiUed Hz<) 
No. of Animals Average Areas ot Spread mm2 
" 5F 
" 
• Da.lly Treatment tor 10 Days 
F • Cutrate Females 
47. 1 =.12.6 
49.6! 12.7 
45.9! 12.S 
• 
• 
• 
, 
, 
, 
RESULTS 
I. The Mammary Gland Spreading Factor in 
Normal Pregnant Animals 
In a nwnber of spt:cies, it has been shown that growth of the mammary 
gland occurs chiefly during the first one-half to two-thirds of pregnancy. 
The duct system first, and later the lobul~·alveolaI system penetrates into 
a fatty pad of connective tissue. The theory had been proposed that the for-
ward progress of the growing gland would be facilitated if cells of the end-
buds of the ducts, and later the growing side-branches which form the 
alveoli, produced a spreading factor which would cause the cementing sub-
stance of the connective tissue to liquify. 
A preliminary investigation by Elliott and Turner (1950) demoosmced 
that such a spreading faeCQr was present in che mammary glands of pregnant 
cats and that it could be extracted and assayed. This bulletin reports on an 
extension of their investigation to determine if the mammary gland spread· 
ing factOr in the rat was present in other species of experimental animals. 
during pregnancy. In addition, these experiments were designed to help 
detetmine whether or not the f.attern of increase in amounts of mammary 
gland spreading factor paralle ed the pattern of growth in the mammary 
gland during pregnancy; thus indicating that the spread ing factor does play 
a pan in extension of the growing mammary gland into the fatty pad. 
TABLE 4- - ASSAY OF SPREADING FACTOR IN RAT MAMMARY EXTRACTS 
Type of Extract 
pH 6 BuIfer 
Testes Extract 
Norma.! F ema.!e· 
1 day pregnant· 
2 days pregnant· 
3 days pregnant" 
4 days pregnant" 
5 days pregnant· 
6 days pregnant" 
7 days pregnant-
6 days pregnant-
9 days pregnant -
10 days pregnant· 
II days pregnant· 
12 days pregnant. 
13 days pregnant · 
14 days pregnant" 
15 days pregnant" 
16 days pregnant" 
17 days pregnant" 
16 days pregnant" 
19 day5 pregnant" 
20 days pregnant· 
21 days pregnant-
_____ .M--'-==mary gland extracts. 
Number 
of Animals 
42 
42 
42 
14 
" 13
18 
23 
" 
" 24 
28 
22 
23 
" 25 
22 
23 
20 
17 
23 
" 13 
16 
Area of 
Spread !11m2 
55.4.13.6 
310.4:; 30.4 
47.7+11 .2 
51.6:; 12.9 
52.6+13.0 
69.9 + 14.6 
83.5 + 16.3 
110.9 + 16.4 
146.4 + 19.3 
196.7+20.2 
229 .9:; 21.3 
234.3 + 23.1 
238.2 + 23.2 
249.0 + 23.7 
260.2 + 24.9 
223.8 + 21.1 
198.5 + 20.1 
160.9 + 19.8 
131.8 + 18.'1 
107.0 + 18.2 
84.0 + 16.5 
79.7 + 15.3 
55.9 -; 13.8 
51.9 -; 13.0 
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The Albino Rat. The preliminary report (Elliott and Turner, 1950) 
showed chat the mammary glands from non-pregnant animals contained 
no spreading faeror, while the mammary glands taken from a large number 
of rats at various Stages of pregnancy showed measurable amounts of spread-
ing factor, except during the first and laSt cwo days. The amount of spread-
ing factor increased with each clay of pregnancy until a maximum was 
reached on about the twelfth day, following which there was a decline in 
amount of spreading factor during the remainder of pregnancy (Table 4). 
As previously shown, growth of the mammary gland during pregnancy 
is considered to be largely completed in from 12 to 14 days in the rat. Fol-
lowing chis period the amount of cellular division slows down greatly and 
milk secretion is initiated. As indicated by data in the present investigation, 
the amount of spreading factor in the mammary gland increased until it 
reached a peak near the time when growth is considered to be largely com· 
pleted after which the amount of spreading factor decreased. Since the num· 
ber of animals used in this investigation was by far the largest for a single 
species, results show dearly the rise and decline in amount of spreading fac-
tor at various stages of pregnancy (Figure 1). 
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Fig. 1. The amount of mammary gland spreading factor in the rat increases 
during pregnancy, reaching a peak on the 12th day. The rise in amount of ~pread­
ing factor parallels the growth phase of mammary gland growth. FollowlDg. the 
peak, the amount of spreading faeto r declines rapidly as gland growth declines 
and seaetory activity i~ iniciued. 
• 
Tbe Albino Mouse. Assays of the mammary glands of normal fe-
male mice indicated that no spreading f.lCtor was present in non-pregnant 
TABLE 5--ASSAY OF SPREADING FACTOR IN MIC E MAMMARY GLANDS 
Type of Extract 
tbrmal Females ' 
4 days pregnant ' 
5 days pregnant· 
6 days pr egnant· 
7 clays pregnant· 
8 days pregnant· 
9 days pregnant· 
10 days prepant· 
11 days pregnant· 
12 days pr egnant' 
13 days pregnant· 
14 days prepant· 
15 days pr egnant· 
16 days pregDant· 
17 days pregnant· 
18 days pr egnant· 
19 days pregnant· 
20 days pr egnant· 
21 days pregnant" 
Number 
of Animals 
5 
5 
• 3 
1 
5 
1 , 
• 3 
3 
3 
3 , 
1 
3 , 
1 , 
"Mammary gLand extracts. 
Area 01 Spread mm2 
52.1 .. 12.5 
100.3:; 13.6 
148.6:; 16.2 
141.9:; 15.7 
152.1..+ 0.0 
182.3:; 20.1 
235.0" 0.0 
234.8 + 17. 2 
263.9" 18.3 
282 .9 + 17.6 
261.4 " 17 .4 
240.6 .. 16.8 
175 .9 + 15.3 
164.0:; 15.5 
122.2:; 0.0 
77.5 :; 14.3 
53 .4 +12.8 
47.1 + 0.0 
47.1'+ 0.0 
g r------------------------------------------, 
'" 
OjO~'1 ~2~3-,4--5c-6C-C7-,8-,Q--tOr-trt-tT2-,13-,,4--t~5-tr6-tT7-,t8-,t9--2~O-2~t 
NUMBER or DAYS MICE PREGNAN T 
. . . 
~ig. 2. The amount of ma':llmary gland spreading factor present in glands 
of ml(e, p~gn:ant up to 12 days, increased similar to that of cats during the grow. 
~ ph.ue. There wu a rapjd decline in spreading f1lctor 2.$ milk $«l'etioo. was iait . 
• ",l 
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animals. First evidence of the presence of the spreading factor was observed 
on the fourth day of pregnancy. At this time, mammary glands contained 
some spreadiag factor. The amount gradually increased with advancing 
pregnancy until a peak was reached on the twelfth day, after which it grad-
ually declined. No spreading factor was detectable in the mammary gland 
extracts from mice pregnant 19, 20 or 21 days (Table 5). 
As pointed out in an orlier section, the period of growth of the mam-
mary gland during gestuion is approximately the same for the mouse and 
rat. ThcedoIe, it is not surprising to find that the amounts of mammary 
gland spreading factor in mice and rats parallel each other during the various 
stages of pregnancy. 
While few mice were employed in this investigation, the curve show-
ing amounts of spreading factor in their mammary glands (Figure 2) during 
pregriancy follows the same pattern as that shown by the tats. 
The Guine2 Pig. As in srudies with the two previous species, mam-
mary glands from non-pregnant guinea pigs showed no spreading factor. 
TABLE 6- -A$SAY OF SPREADING FACTOR FROM GUINEA PIG 
MAMMARY GLANDS 
Type of Elrtract 
Norm:ll. F emales· 
5 days pregnant· 
7 days pregnant· 
10 days pregnant" 
13 days pregnant· 
15 days pregnant" 
18 days pregnant" 
20 days pregnant" 
22 days pregnant" 
25 days pregnant" 
28 days pregnant· 
30 days pr egnant· 
33 days pregnant" 
35 days pregnant" 
36 days pregnant" 
36 days pregnant" 
40 days pregnant" 
41 days pregnant" 
43 days pregnant" 
45 days pregnant" 
47 days pregnant" 
50 daYs pregnant" 
53 daye pregnant" 
55 days pregnant" 
58 days pregnant" 
60 days pregnant" 
62 days pregnant" 
66 days pregnant '" 
67 days pregnant" 
Nu.mber 
of AnimalS 
, 
1 , 
, 
, 
3 , 
3 , 
3 
3 
3 , 
3 
1 
3 , 
1 , 
1 
3 
3 , 
, 
1 
3 , 
1 
1 
-Mammary gland e:rtracts. 
Area of Spread mm2 
50.3 + 12.9 
53.4:;: 0.0 
61.4 -; 13.9 
76.0:;: 14.4 
93.3 :;: 14.9 
64.7:;: 14.7 
122.1:;: 15.1 
141.9:;: 15.3 
171.9:;: 15.4 
200.6;- 15.6 
220.1 ;- 16.0 
243.5:;: 16.5 
256.8 ;- 16.3 
266.2 -; .16.8 
252.3 -; '0.0-
270.3 -; .l'6.3 
303.3 -; 17.1 
327.3 -; 0.0 
303.1 +n.o 
296.6 -; 0.0 
252.5 -; 16.3 
261.3 -; 16 .5 
209.1 -; 15.6 
189.0 -; 15.1 
115.1 -; 0 .0 
82.9 -; 13.2 
59.9 + 12.7 
53.4 -; 0.0 
53.4 -; 0.0 
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Mammary glands from guinea pigs pregnant ~ and 7 days also showed no 
spreading factor. Extracts of glands from animals pregn~nc 10, 13, and. l~ 
days indicated the presence of small amounts of the spreading factor. Dunng 
(he rest of early pregnancy, there was an increase in amount of spreading 
factor in the mammary glands until a peak was reached on about the forty-
first day, after which the amounc declined. By the sixtieth day of pregnancy, 
very little spreading factor could be detected in the mammary gland an~ on 
the sixcy.seoond day, assays showed none. Mammacy glands from cwo guinea 
pigs at parturition, pregnant 66 and 67 days, showed that no spreading fac-
tor was presc=nc (Table 6). 
Here, again, the amoum of spreading factor parallels gtowth of the mam· 
mary gland during pregnancy (Figure 3). As in the case of growth, little 
~.-------------------------------, 
g 
o~'""''''~~~~~~~~~ " ~ 10 15 2025 3 0 3~ 40 "5 ~o 55 o 05 
NUMBER or DAYS GUINEA PIGS PREGNAN T 
Fig.~. In the guinea pig, wi th a long period of pregnancy, rise in the a-
mount of spreading betor preSent in mammary glana , was gradual up to the 
peak at 40 to 45 days. The subse<luent decline in spreading {:letor with cessniOD 
of growth and initiation of lactation was fairly upid . 
spreading factor activity is present before the fifteenth day. After l~ days 
both increase gradually. The peak amoum of spreading factor was observed 
on the fony-first day of pregnancy. While the growth period of the mam-
mary gland during pregnancy is not known, the two-thirds point of preg-
nancy, probably the time of maximum growth, would fall becw~n 40 and 
45 days. Thus, the maximum spreading factor activity and maximum mam-
mary gland growth during pregnancy occurred at about the same time in 
the guinea pig. Decline in amounts of the spreading factor after the fony-
first day also agrees with the decrease in numbers of mitotic figures known 
to occur in mammary glands during this period of pregnancy. 
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The: Rabbit. Assays of mammary glands of non-pregnant rabbits 
showed that no spreading factor W:lS present. Mammary glands from the 
TABLE 7.·ASSAY OF THE SPREADING FACTOR IN RABBIT MAMMARY GLANDS 
Type of Extract 
Normal Females" 
-4 days pregnant· 
7 days pregnant · 
9 days pregnant · 
10 days pregnant" 
11 days pregnant· 
12 days pregnant · 
13 days pregnant· 
U days pregnant" 
15 days pregnant · 
16 days pregnant" 
17 days pr egnant" 
18 days pregnant-
19 days pr egnant" 
20 days pregnant" 
21 days pregnant" 
22 days pregnant" 
23 days pregnant-
25 days pregnant" 
28 days pregnant-
"Mammary gland extracts 
Number 
of-An.tmals 
3 
1 
2 
2 
2 
1 
2 
2 
2 
2 
1 
2 
2 
2 
2 
2 
2 
, 
2 
1 
Area of Spread 10m2 
51.3 + 12.9 
66.0:; 0.0 
107.5+14.3 
129.7" 14.4 
159.9"+ 15.3 
152.0:; 0.0 
164.0:; 15.1 
184.3"+ n.s 
239.1" 16.9 
230.3 .. 16.3 
252.6:; 0.0 
270.4:; 16.8 
305.7+1 7.4 
284.5 :; 17.0 
270.5:; 16.8 
221.8:; 17.1 
176.0:; 1$.2 
1$4.3 :; 0.0 
114.$:; 14.3 
53.4 :; 0.0 
FigA. The rise and decline in amount of mammary gland spreading faeror 
in the pregnant rabbit, in relation to $rowth and the initiation of milk secretion, 
follows the pau ern of the other species. 
• 
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earliest stage of four days of pregnancy showed link or no spreading factor, 
the next stage, 7 days, showed that spreading factor was present. The a-
mount of mammary gland spreading facto r increased to a peak on the 
eighteenth day of pregnancy. after which there was a gradual decline. By 
the twenty-eighth day of pregnancy no spteading factor was detectable in 
the mammary gland extracts (Table 7). 
Increase in amounts, a peak at the eighteenth day, and a decline in a-
mounts of spreading factor during pregnancy (Figure 4) check with the 
pattern of mammary gland growth occurring in the pregnane rabbits (Fig-
ure 4). 
Summary. Investigation of four species of experimental animals has 
shown that the increases in amounts and times at which peak amounts of 
the spreading faccQt'were observed in the glands during pregnancy closely 
parallel the growth phase of mammary gland development. D uring the 
latter one-third of pregnancy, when cells of the mammary gland begin se-
cretion, amounts of the spreading fac tor decline. It would appear that elabor-
ation or activation of the spreading factor practically ceases as secretory 
activiry begins. 
11. Effects of Hormones on the Mammary 
Gland Spreading Factor 
It has been shown that a number of hormones separately or together" 
stimulate growth of the mammary gland. Among the more important of 
these hormones is estrogen which has been shown to cause duct growth, an 
estrogen and progesterone synetgism which has been shown to cause lobule-
alveolar growth, and an anterior pituitary hormone which has been called 
mammogen (Turner, 1950). Effects of these various hormones on the elabor-
ation or activation of the mammary gland spreading factor were studied. 
The Ovarian H ormones. In a preliminary study (Elliott and Turner, 
1951b) . various levels of the ovarian hormones were injected daily either 
separately or together into groups of fi ve castrate ratS for 10-<lay periods. 
Mammary gland extracts from castrate females injected with 1 ug. of 
estradiol benzoate showed little spreading facror. When the estradiol benzo-
ate level was raised to 3 ug., the extracts indicated fair levels of the spreading 
factor. Mammary gland extracts from castrate male and female rats trea.ted 
with 5 ug. of estradiol benzoate indicated rhe presence of more spreading 
facror (Table 8). 
These data indicate that estrogen can cause production of the active 
mammary gland spreading factor the same as it has been shown to induce 
mammary duct growrh. Ir would appear that this hormone, which initiates 
extension of che mammary duct system into the fatty pad, causes elaboration 
or activation of the spreading factor which may.help in the forward exten-
sion of these ducts through the connective tissue barrier. 
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With progesterone alone the amount of spreading factor in the mam-
mary gland extracts was small at the 1 mg. level in castrate females. An 
increase in the amount of progesterone to 3 mg. caused a higher level of 
spreading facror to be presenc in the mammary extracts of castrate females , 
while a 5 mg. level of progesterone injected into castrate males, castrate fe-
males and castrate adrenalectomized females showed a furchcr increase and 
indicated fair amounts of the spreading factor to be present in the extracts. 
Ten mg. of progesterone increased the amount of spreading factOr in cas-
tnte adrenalectomized females, as well as castrate males and females giving 
the highest level of mammary gland spreading factor obtained from any of 
the progesterone injected groups (Table 8). 
TABLE S--EFFECTS OF ESTROGEN AND PROGESTERONE ON AMOUNTS OF 
SPREADING FACTOR IN RATS· 
Mammary Elrtracts ~m Rats 
Treated With: 
1 ug estradiol benzoate 
3 ug estradiol benzoate 
5 ug estradiol benzoate 
5 ug estradiol benzoate 
5 ug estradiol benzoate 
1 mg progesterone 
3 mg progesterone 
5 mg progesterone 
5 mg progesterone 
5 mg progesterone 
10 mg progesterone 
10 mg progesterone 
10 mg progesterone 
1 ug E. B. + 1 mgprog. 
1 ug E. B. + 3 mg prog. 
1 ug E . B. + 5 mg pro,. 
1 ug E. B. + 5 mg prog. 
3 ug E. B. + 1 mg prog. 
3 ug E. B ... 3 mg prog. 
3 u, E. B. + 5 mg prog. 
5 ug E. B . .. 1 mg prog. 
5 ug E. B ... 3 mg prog. 
S ug E. B ... 5 mg prog. 
*DaUy treatment lor 10 days 
M '" Castrate Male 
Adren. '" Adrenalectomized 
No. of Animals 
and Sell; 
5F 
5 F 
5 F 
5M 
5 F Adren. 
5F 
5F 
5 F 
5M 
5 F Adren. 
SF 
5 M 
5 F Adren. 
5 F 
5 F 
5 F 
5 F Adren. 
SF 
5 F 
5 F 
5 F 
5 F 
5 F 
Area 01 Spread 
mm2 + S. D. 
12.3 .. 12.3 
'55.5; 16.3 
176.0; 14.6 
171.0; 13.7 
79.9; 12.6 
12.3 .. 12A 
97.4 ; 13.3 
114.1; 14.8 
10<1.6; 15.2 
107.4; 13.9 
191.3" 16.3 
184.2; IS. 1 
193A" 11.4 
60.2 .. 11.9 
168A" 13 .2 
208.6" 14.6 
212.3; 13 .1 
8l.6" 12.5 
160A ; 13.1 
179.6;14.1 
129.1; 13.8 
141.2 .. 16.9 
US.O" 14:7 
F _ Castra.te Fe male 
Prog . • Progesterone 
E. B. '" Estradiol benzoate 
This investigation sbowed that progesterone also was effective in ClUS-
ing elaboration or activ:aion of the mammary gland spreading factor, in-
diClting that the spreading facror is involved also in mammary lobule-al-
veolar development, possibly by breaking down the connective tissue bar· 
rier before the growing buds. 
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The combination of 1 ug. of estradiol benzoate with 1, 3 and 5 mg. of 
progesterone injected into castrate males and females gave increasingly larg-
er amounts of mammary gland spreading factOr. When the amount of 
estradiol benzoate was raised to 3 ug. in combination with 1, 3 and 5 mg. of 
progesterone the responses were not quite as great but showed the same 
graded effect. Raising the estradiol benzoate level to 5 ug. with the above 
amountS of progesterone gave uniformly smaller amounts of the spreading 
faeror in mammary gland extractS (Table 8). 
Combinations of estrogen and progesterone follow the same pattern 
of effect on the spreading factor that has been shown on mammary gland 
growth. The ratio of optimum synergism between estrogen and progest-
erone is 1 to 3000-5000 on a gravimetric basis as measured by the elabora-
tion or activation of the spreading factor. 
Since the combination of 1 ug. of estradiol benzoate and 5 mg. of pro-
gesterone daily for 10 days gave the greatest amountS of the mammary 
spreading factor in treated animals, it was decided to try this same combina· 
tion of estrogen and progesterone for longer periods of time. These ovarian 
hormones were injected daily into separate groups of five castrate female 
racs foc periods of 12, 15, 20, 25 and 30 days. The amounts of spreading fac-
tor in the mammary gland extracts of gtoups receiving hormones for 12 and 
15 days was larger than in those which received hormones for only 10 days. 
The groups which received hormone treatment for 15 days showed the 
greatest amount of mammary spreading factOr. The groups of rats which 
received hormone treatment for 20-, 25- and 30-day periods showed pro-
gressively smaller amounts of the spreading factor in the mammary gland 
extracts (Table 9; Figure 5). 
These data indicate that the combination.of estrogen and progesterone, 
which causes growth of the mammary lobule-alveolar system comparable 
co thac observed in 'pregnancy, also stimulates the elaboration or activation 
of the mammary gland spreading factor to a degree comparable to that ob-
served at the peak of pregnancy (Compare Table 9 wich Table 4). 
With contmued injection of these hormones, growth of the mammary 
glands gradually subsides (Gardner, 1941). Gradual decline in elaboration 
or activation of the spreading factor, under similar hormone treatment, fur-
ther supports the hypothesis that this factor is elaborated or activated only 
in the growing mammary gland cells. 
If the amount of spreading factor that can be extracted from a mam-
mary gland is related to the number of growing cells present in the gland, 
a considerable difference would be expected in the amount of spreading 
factor thac could be extracted from glands of animals in which duct growth 
had and had nOt taken place previous to castration, since the numbers of 
cells in the animals with duct growth would be much larger than those 
without. 
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TABLE 9--SPREADING FACTOR IN HORMONALLY TREATED RATS 
Mammary Extracts From Rats 
Treated for 
No. of Animals 
md "'" 
Area of Spread 
mm2 .. S. D. 
Effect of Length of Treatment Time on Amount of Spreading Factor 
12 days 
15 days 
20 days 
25 days 
30 days 
in Hormonally Treated Rats* 
5F 
5 F 
5 F 
5F 
5 F 
212.5 .. lS.3 
249.3:; 16.2 
182.0:; 15.6 
122.4:; 16.1 
83.7"+ 14.1 
EFFECT OF SIZE OF MAMMARY GLAND ON AMOUNT OF SPREAD. 
lZ days 
12 days 
ING FACTOR IN HORMONALLY TREATED RATS-
51F 
5 MF 
• 1 ug estradiol benzoate .. 5 mg progesterone dally 
F " Castrate female 
IF .. Female eastrate at 40 - 50 grams weight 
MF .. Female castrate at 175 grams weight 
160.8 .. 19.1 
207.4:; 17.3 
~,---------------------, 
> 
Fig.5. When groups of ots were admiDistered esuogen :ilod progesterone 
in the optimal synergistic proportions for 30 d:.l.ys, it was observed that the a-
mount of spreading Hcror present incrased until the 15th day followed by a gr:td. 
wl decline. Since lactation is not a factor in this ase, the decline is interpreted 
as:lll indication of the declining growth response of the mammary glana with 
continued hormone injection. 
• 
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To det~mine if sucb a relationsbip existed several groups of rars were 
treated with estrogen and progesterone. One was a group of macure females, 
castrated when tbey had reacbed a weight of In g rams. T he ocher was a 
group of young females, castrated when chey weigbed between 40 and 50 
grams. When botb groups of castrate animals reached a weight of about 
180 to 200 grams they received 1 ug. of estr2.diol benzoace and 5 mg. of pro-
gesterone daily fo r 12 days. Examination of castrate controls from both 
groups revealed that the g roup of rats castrated young had smaller mam-
mary glands than animals castC2ted after they were mature. Assays of the 
mammary gland extracts from treaced animal s showed that those which 
were castrated after reaching maturity had more spreading factOr than those 
castrated while very young (Table 9). Mammary glands of the treated ani-
mals also appeared to be larger in rats castrated afeer reaching maturity. 
These data indicate that the number of ceUs in the mammary gland is 
related to the amount of spre2ding factor; however, this investigation did 
nOt indicate that a direa relationship between size of the gland and amount 
of spreading factOr existed, since no method is now avaiJable for the direa 
determination of cell number. 
A further investigation of the ability of estrogen and estrogen and pro-
gesterone to cause elaboration or activation of the mammary gland spread-
ing factor was tried on the mouse. A series of tte3tments with estrogen and 
estrogen and progesterone was made on groups of five castrace female mice 
for lO-day periods. . . '. 
Three separate groups of mice received 0.5, 1.0 and 2.5 ug. of estradiol ' 
benzoate daily for che 100day period. Groups receiving 0.5 and 1.0 ug. of 
escrogen daily showed no mammary gland spreading factor. Assays of mam-
mary gland extracts from the group which received 2.5 ug. daily showed 
only moderate amounts of the spreading factor to be present. 
In the mouse, as in the Illt, estrogen is shown co be eff'eaive in causing 
elaboration or aCtivation of the mammary gland spreading factor. Thus, in-
dicating further that the spreading factor is associated in mammary duct 
growth. 
Daily injeCtions of escrogen together with progesterone into groups of 
mice showed thac the combination of 0.5 ug. of estradiol benzoate and 0.5 
mg. of progesterone gave the largest amounu of the spreading factor in 
mammary gland extracts. The same level of estrogen in combination with 
0.2~ and 1.0 mg. of progesterone gave smaller masurable amounts of the 
spreading faecor. When 0.5 mg. of pro~terone was tried with 0.25, 1.0 and 
2.0 ug. of esu adioiJ benzoate, little or no spreading faCtor was present in 
mamrmry gland extracts (Table 10). For normal concrol see Table ~. 
The 0rtimal combination of estrogen with progesterone showed that 
the C2tio 0 syn~gism for elaboration or activation of the mammary gland 
spreading factor in the mouse was best at 1 to 1,000. Results also showed 
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TABLE 10-·EFFECTS OF ESTROGEN AND PROGESTERONE ON AMOUNTS 
OF SPREADlNQ FACTOR m MICE~ 
Mammary Elrtraetl From Mice 
Tl"eated With: 
O.~ UJ extradiol benzoate 
1.0 1.1, estradiol Mn'ZOate 
2.& ug estradiol benzoate 
0.5 u.i E. B . ..: 0.25 mg prot. 
0.5 iii E. B. + 0.5 mg prog. 
0.5 ug E. B ... 1.0 IIlIiI: prog. 
0.25 ug E. 8 ... 0.5 ms prog. 
' .0 ug E. B ... 0.5 mg prog. 
2.0 ug E. B ... 0.5 mg prog. 
. Da.lly treatment for 10 days 
F a Castrate female 
E. B. " Estradiol bem:oate 
Prog. " Progesterone 
No. of Animals Area of Spread 
'""'" 
mm2 ... S. D. 
SF 50.9 ... 12.6 
S F U.8:; 13 .0 
SF 109.4 -; 29.1 
SF .84.3 ... 13.4 
S F 209.2" 33.8 
SF · 12?7~23.8 
SF 74 .S .. 18.9 
SF 112.1 :; 27.1 
SF 78. 1 +" 29.1 
that e<Jtlally good production of the SpIe2d.ing factor occurred in the mou~ 
and rat per unit of gland. Further, the results show that estrogen :lna pro-
gesterone, in the optimum ratio, are nearly as effective in causing ehbora-
cion or ll.ctivation of the spreading factor in (reared mice as Wll.S found at a 
comparable stage of pregnll.ncy. (Compare T:able 10 (0 Table ). 
The Pituit2.cy Hormones. Certain :anterior piruit2.ry fractions have 
been shown to stimulate duct 2nd lobule-alveolar growth in the mammary 
glands of castrate animals. As previously noted, estrogen has a synergistic 
effect with pituitary fractions on mammary gl:and growth. Investigation to 
determine the pituiury fraction responsible for m:ammary gland growth has 
shown pituit:ary extr:acts rich in lactogenic hormone to be most effective. 
However, there is still doubt:as to the purity of these extracts. 
In a preliminary study (Elliott :and Turner, 19)1b), an attempt was 
m2de to determine the effectiveness of the pituiury in C2using elaboration 
or activation of the mammary gl:and spreading faCtor. An :a.cetone powder 
of the anteriot pituiury of c:attle was employed. Ten mg. of this powder in 
water suspension W2S injected into five C2Stnte female rats daily for 10 days. 
Another group of 10 C2Stnte fenu.le rats were injected with the same amount 
of the anterior pituitary mction plus 1 ug. of estradiol benzoate daily for 10 
days. 
The group which received the pituit2ry fraction alone showed :a. small 
amount of spreading f:actor in m:ammuy gl2nd extr:acts, while the group 
which received botb estrogen :and [he pituitary fnction showed brgtt:a-
mounts of the spreading factor. T hese results :are in accord with reportS in 
the literature showing that pituitary extracts with estrogen give greater 
stimulation of ma.mmary gland growth than the pituitary extnctS alone. 
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Another series of investigoaions was undertaken to determine the piNi-
tary fraction responsible for ela~oration or ~ctivation of the mammary gland 
spreading factor. At the same time, expenments were conducted to deter-
mine if an active pituitary fraerion was produced by estrogen or estrogen and 
progesterone treatment of castrate animals. 
Groups of five cascrate female mice were injected daily with purified 
pituitary fractions or crude extracts from hormonally treated rats for 10-day 
periods. Groups which received pituitary fractions containing 3 mg. (60 
I. U.) oflactogenic hormone daily showed good elaboration or activation 
of the mammary gland spreading factor. Other groups which received se-
parate pituitary fractions rich in growth hormone, thyrotropic hotmone, 
gonadotropic hormone and melanaphore factor in the amount of 3 mg. daily, 
showed little or no spreading factor in the mammary gland extracts. 
A group of mice which received 05 ug. of estradiol benzoate plus 20 
mg. daily of anterior pituitary powder from normal ratS showed no mam-
mary gland spreading factor. A group which received, daily, 0.:5 ug. of estrad-
iol benzoate, plus 20 mg. of pituitary powder from castrate female rats treat-
ed with I ug. of escradiol benzoate daily for 10 days, also showed no mam-
mary gland spreading factor. However, assays of mammary glands from a 
group of mice which received, daily, 0.5 ug. of estradiol benzoate, in addi-
tion to 10 mg. of pituitary powder from castrate female rats created with 
1 ug. of estradiol benzoate and 3 mg. of progesterone daily for 10 days, show-
ed measurable amounts of the spreading factor to be present (Table 11). 
These data show that of the purified pituitary fractions, only the one 
rich in lactogenic hormone was effective in eausing elaboration or activation 
of the mammary gland spreadng factor. Pituitary fractions rich in growth 
hormone, gonadotropic (FSH) hormone, thyrotropic hormone and melana-
phore factor were ineffective in causing elaboration or activation of the 
spreading faeror. Assays of the crude pituitary powder showed that only the 
one from castrate ratS receiving estrogen and progesterone treatment had 
any power to cause production of the mammary spreading factor. 
These investigations indicate that a pituitary fraction rich in lactogenic 
hormone can cause good e1aboraton or activation of the mammary gland 
I spreading factor just as it has been shown to induce mammary gland grow-
th. However, there is still the possibility that the mammogenic action of 
this pituitary substance is caused by a contaminant which is a separate frac-
tion from the lactOgenic hormone. Investigation of the crude pituirary frac-
tions makes it appear that treatment with estrogen and progeSterone may 
have caused secretion of the active pituitary hormone in caStrate female rats 
because the pituitary extracts from these rats caused elaboration or activa-
tion of the mammary gland spreading facror when injecred inco mice. These 
data agree with findi ngs that pituitary extracts from animals treated with 
estrogen and progesterone stimulated growth of the mammary gland. 
TABLE It- -EFFECTS OF PIT UITARY EXTRACTS ON THE AMOUNT OF SPREAD_ 
ING FACTOR IN MICE AND RATS* 
Mammary Extracts From Mice 
Treated With: 
3 mg Lactogenic Hormone~ 
3 mg Lactogenic Horrtlone 
3 IIlg Growth Hormone! 
3 109 Growth Hor~ne2 
3 mg Gonadotropin (FSH) 
3 mg ThyrotroPlnl 
3 IIlg Melanophore Factor l 
10 mg A. P. extract 
1 ug E. B. + 10 mg A. P . extract 
0.5 iii E. B. + 20 mg A. P . extract3 
0.5 ug E. B. + 20 mg Pitultar y4 
0 .5 ug E. B. + 10 mg Pituitary5 
- Oally Treatment for 10 days, 
Lactogenic Hormone, 3 mg. = 60 I. U. 
FM = Castrate female mice 
FR z Castr ate female rats 
1 • Armour Pituitary Fr actions 
2 • Squibb Pituitary Fractions 
No. of Animals 
~d 50>< 
5 FM 
5 F M 
5 FM 
5 FM 
5 FM 
5 F M 
5 FM 
5 FR 
10 FR 
5 FM 
5 FM 
5 FM 
S * Pituitary extr acts f rom normal female rats 
Area of Spread 
mm2 + S. D. 
215.0 + 11 .9 
202.4 :; 24.S 
65.2:; 19.7 
68.0 + 26.7 
57.3 + 13 .0 
57.2:; 12.6 
57.7! 13.0 
114 .7 + 16 .5 
192.5 + 28.3 
53.5+13 .0 
67.9 + 19 .6 
125 .1 + 36 .2 
4 • Pituitary extracts f rom castr ate female r ats getting 1 ug. estrogen daily 
lor 10 days. 
5. Pituitary extracts from casttate female rats getting 1 ug. estr ogen + 5 mg. 
progesterone dally for 10 days. 
Effect on H yp ophysectomized Rats. In a previous section it was 
pointed out that a number of investigators found the ovarian hormones to 
be ineffective and an anterior pituitary hormone effective in stimulating 
mammary gland growth in hypophysectomized animals. To check the effects 
of these hormones on the elaboration or activation of the mammary gland 
spreading factor in hypophysectomized animals, groups of mature castrate 
and castrate· hypophysectomized male Sprague-Dawley rats were injected 
with hormones for lQ-day periods. 
One group of six castrate rats which received 0.:5 ug. of estradiol benzo-
ate showed no spreading factor in the mammary gland extracts. Assays of 
the mammary gland extractS from another group of six castrate rats which 
received 1 ug. of estradiol benzoate, 5 mg. of progesterone and 60 I. U. (3 
mg.) o(a pituitary fraction rich lactogenic hormone showed large amounts 
of the factor to be present. 
A group of fi'le castrate-hypophysectomized rats which received 1 ug. 
ofestradiol benzoate and 60 I. U. (3 mg.) ofa pituitary fraction rich in lac-
togenic hormone also showed large amounts of spreading nctor in the 
mammary gland extracts. However, a group of six casrrate-hypophyseetD-
. mized ratS which received 1 ug. of estradiol benzoate and :5 mg. of pro-
gesterone showed no spreading nCtOr in the mammary gland extracts. As-
says of a final group of five castrate-hypophysectomized rats which received 
1 ug. of estradiol benzoate, :5 mg. of progesterone and 60 I. U. (3 mg.) of 
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a pituitary fracdon rich in the lactogenic hormone showed large amounts 
of the spreading facror in the mammary gland extracts, (Table 12). 
TABLE 12--EFFECTS OF HORMONE TREATMENT ON AMOUNTS OF 
SPREADING FACTOR IN HYPOPHYSECTOMIZED RATS. 
Mainmary Extracts From Rats 
Treated With: 
0.5 ug. Estradiol Benzoate 
1.0 ug. E. B. , 5 mg. Pr0'Y 
+ 60 1, U. LactogeniC H. 
1.0 ug. E. B. + 60 I. U. 
Lactogenic Hormonel 
1.0 ug. E. B. + 5 mg. Prog. 
1.0 ug. E. B. , 5 mg. Prog. 
60 I. U. LactogeniC H. 
·Daily treatment for 10 days 
M a Castrate Sprague-Dawley rats 
No. of Animals 
"'" So. 
'M 
'M 
5 HM 
, HM 
5 HM 
lIM = Castrate_hypophysectomized Sprague-Dawl ey rats 
1 "' Squibb pituitary fraction 
Area of Spread 
1l1.Il).2 + S. D. 
45.0 + 10.4 
198.0 + 37.2 
200.6 + 23.7 ' 
45.0"+ 10.4 
206.4 + 34 .6 
Here again it can be noted that hormone treatment elicits a pattern of 
response of the spreading factor similar ro those reported in stimulating 
mammary gland growth. Estrogen and progeSterone, which are ineffective 
in stimulating mammary gland growth in hypophysectomized animals, also 
are ineffective in causing the elaboration or activation of the spreading fac-
.ror in hypophysectomized rats. Combinations of the piruitary fraction rich 
in lactogenic hormone with estrogen or estrogen and progesterone are as 
effective in castrate-hy}X)physectornized rats as in the castrate rats in causing 
production of an active spreading factor. 
These results are consistent with results obtained by other investigators 
in stimulating mammary gland growth. It also can be seen from these data 
that progesterone does not aid estrogen and the fraction rich in lactogenic 
hormone in causing elaboration or activation of the spreading factor. 
These data are believed to provide further evidence for the theory that 
one of the chid functions of estrogen is to act locally upon the mammary 
gland, increasing the vascularity and permeability of capillary blood vessels. 
Primary function of progesterone in mammary gland growth, on the other 
hand, is to stimulate secretion of the mammogenic hormone of the pitui-
tary. In the absence of the pituitary it is ineffective. In hypophysectOmized 
animals, progesterone does not synergize with estrogen when the mammo-
genic hormone is administered. 
The Androgens. In determining the effects of androgens on the 
elaboration or activation of the mammary gland spreading factor, treatment 
with a level of testosterone known ro stimulate mammary gland growth was 
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employed (Elliott and Turner, 19~ 1 b). Groups of five castrate males and 
females were injected daily with 1 mg. of testosro=:rone for 10 days. Mam-
mary gland extracts from boch of these groups indicated only fair amounts 
of the spreading factor to be prest:nt (Table 13). 
TABLE l3_·EFFECTS OF TESTOSTERONE, CORTISONE AND DESOXYCORTIC· 
OSTERONE ON AMOUNTS OF SPREADING FACTOR IN RATS-
Mammary Extracts From Ralll 
Treated With: 
1 mg Testosterone 
1 IIlg Testosterone-
1 ag. E. B. + 1.5 mg. Cortisone 
Acetate 
1 ug. E. B. + 2.5 mg. desoxy-
corticosterone acetate 
*Oa.Ily Treatment for 10 days 
E. B ... Estradiol benzoate 
F .. Castrate fema!e 
M z Castrate male 
No. of Animals 
"'" SOx 
5F 
5M 
5F 
5F 
Area of Spread 
mm2 + S. D. 
144.6 + 23.7 
159.5'+ 26.3 
103.6 + 18.9 
169.7 + 22.4 
As'has seen shown in the case of mammary gland growth, testosterone 
can cause elaboration or activation of the mammary gland spreading faccor 
when administered at a high level. However, since the majority of the Stu-
dies deal with female hormones, no further investigations with effects of 
male hormones on the mammary gland spreading factor were made. 
Adrenal Cortical Hormones. It has been shown experimentally that 
estrogen can stimulate duet and some lobule-alveolar growth in a number 
of animals with intact adrenals. Ability of estrogen to cause this growth was 
greatly reduced when adrenals were removed (Trentin and Turner, 1948). 
It has also been shown that estrogen can stimulate adrenal cortical activity. 
In view of these facts. it has been postulated that growth of the mammary 
gland in response to estrogen treatment, may be due to the ability of estrO-
gen to cause the adrenal cortex to produce steroids which are either identical 
with or closely resemble progesterone in its ability to synergize with estro-
gen in stimulating such growth. Moreover, it has been proven that the ad-
r~nal compound desoxycorticosterone can be converced to progesterone in 
VIVO. 
As previously reported (Elliott and Turner, 19S1b), the ability of es-
trogen to cause elaboration or activation of the mammary gland spreading 
factor is better in animals with intact adrenals, indicating that pare of the 
effect of estrogen is due to ability of estrogen to cause production of an ad-
renal compound which synergizes with estrogen to cause elaboration or 
activation of the spreading factor. Thus, it would appear that part of the 
spreading factor and mammary gland growth produced in response to es-
trogen is mediated in the same manner, i.e., by way of the adrenal. 
, 
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In continuing investigation of the role that the adrenal cortex plays, it 
was decided that several cortical compounds known to stimulate mammary 
gland growth should be tested for their effect on the spreading factor. One 
group of five castrate female rats received 1 ug. of estradiol benzoate plus 
1.5 mg. of cortisone acetate daily for 10 days. A second group of five castrate 
female rats received 1 ug. of estradiol benzoate plus 3 mg. of desoxycorti-
costerone acetate daily for 10 days. Assays showed measu rable amounts of 
spreading factor to be present in the mammary gland extractS of both groups. 
The grour which received desoxycorticosterone acetate showed larger a-
mounts a the spreading factor (Table 12). 
These data indicate that adrenal compounds which stimulate mammary 
gland growth can cause elaboration or activation of the spreading factor. 
This investigation also adds support to the idea that adrenal cortical com-
pounds produced in response to the presence of estrogen may account for 
part of the mammary gland growth in escrogen treated animals. 
Rdaxio. It has been shown experimentally that relaxin may act as a 
potentiator of estrogen in inducing mammary gland growth. However, in-
vestigations have shown that relaxin does not aid or act as a substitute for 
progesterone in inducing mammary gland growth. Preliminary investiga-
tions (Elliot[ and Turner, 19:511), indicated that relaxin was not the mam-
mary gland spreading factor and that the mammary gland spreading factor 
did not cause pelvic rdaxation in the guinea pig. 
The present investigations were designed to show the effect of relaxin 
on the elaboration or activation of the mammary gland spreading factor 
when administered in connection with estrogen and progesterone. 
Groups of five castrate female rats were injected daily with various levels 
of relaxin together with a number of combinations of estradiol benzoate and 
progesterone, as well as various levels of the individual steroid hormones, 
for 10 day periods. 
Assays on mammary gland extracts from groups of animals which re-
ceived 25 guinea pig units of relaxin in addition to 1 and 5 ug. of estradiol 
benzoate, 5 mg. of progesterone, and 1 ug. ofestradiol benzoate plus 5 mg. 
of progesterone failed to show more spreading factor than was obtained 
from the same levels of estrogen and progesterone alone. Mammary gland 
extracts of animals which received 100 guinea pig units of relaxin in addi-
tion to 1 ug. of estradiol benzoate showed more spreading factor than those 
from animals which received the estrogen alone. However, 100 guinea pig 
units of relaxin tOgether with 1 ug. of estradiol benzoate and:5 mg. of pro-
gesterone failed to cause more spreading factor in mammary gland extracts 
than the same levels of estrogen and progesterone without relaxin. 
Results of experiments in which 1 ug. of estradiol benzoate was in-
jected tOgether with 200 guinea pig units of relaxin, daily, showed that the 
addition of this level of reLt.xin co estrogen caused a large increase in the 
amount of the spreading f2ctor over the estrogen alone. Relaxin, alone, even 
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at this high level, failed to cause elaboration or activation of the mammary 
gland spreading factor (T able 13). 
Experimental evidence seems to show th:l.t relaxin is ineffective alone 
and as an aid to progesterone or estrogen and progesterone in causing elab-
oration or activation of the mammary gland spreading facror. Relaxin in 
progressively higher levels, however, seems to cause estrogen to be more 
effecdve in producing the mammary gland spreading factor. The same pat-
tern of response has been shown with relaxin in mammary gland growth by 
some ocher investigators. It, therefore, appears that relaxin in sufficiently 
high dosage may synergize with esuogen in stimulating production of the 
mammary gland spreading factor, but it has no syn~gistic effect when added 
to combinations of estrogen and progesterone. 
Summary. These investig:uions have shown that various combina· 
tions of eStrogen, progesterone, anterior pituitary fractions, testosterone, 
adrenal cortical hormones and relaxin are aU effective to a-greater or lesser 
degree in causing elaboration at activation of the mammary gland spreading 
factor. These data are believed to indicate that the hormones which stimu· 
late variable degrees of duct and lobule-alveolar growth of the mammary 
gland also stimulate production of the mammary gland spreading factor 
to comparable degrees. 
lll.CharaCteristics of the Mammary Gland 
Spreading Factor 
The research was designed, primarily, to investigate physiology of the 
mammary gland -spreading factor; however, a few facts concerning its char· 
acteristics were investigated. In a preliminary report (Elliott and Turner, 
1950), it was shown that the mammary gland spreading factor did not hy· 
drolyze the substrate hyaluronidate, and, therefore, probably was not identi-
cal with the spreading factor, hyaluronidase. It was further shown in stu-
dies of itS enzymatic characteristics that the mammary gl:md spreading fac-
tor differed from hyaluronidase in its inactivation by heat. 
In investigating the possibility that t he mammary gland spreading fac· 
tor was hyaluronidase, a turbidimetri'C method of assay for hyaluronidase 
was employed (Tolksdorf et al., 1949). Several preliminary assays conducted 
with purified hyaluronidase indicated the reliability of potency of the enzy· 
me preparation and the reproducibility of the method. Assays were made on 
mammary gland extracts from rats pregnant 6, 7,8,9, 10 and 11 days. In no 
case did any of these mammary gland extracts give indication of hydrolyz· 
ing the substrate hyaluronidate (Table 14). 
. Since it was deemed necessary that the enzymatic charaeter of the mam-
mary gland spreading factor be checked, a number of assays were made to 
determine irs inactivation temperature. Testicular extracts containing hyal-
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TABLB H __ EFFECTS OF RELAXIN ON THE AMOUNT OF SPREADING 
FACTOR IN RATS" 
., 
Mammary Elrtract~ From Rats No. of Anlmale Area ot Spread 
. Tr'eaied With; 
... "" mm2 .. S. D • , 
lUi. E. B ... 25 O. P. lJ. 
Relu1n 
" 
8e.4 ~ 14.1 
5 ",. E. B ... 25 O. P. U. 
....... 
" 
lIiIl.7 ~ 18.5 
5 mg. Prof ... 25 G. P. (1. 
Relax1n 
" 
114.7 .. 14.5 
1 Ui. E. B ... 5 m,. Pro, ... 
• 25 G. P. U. Reloin 
" 
20$,0 .. 16.~ 
• 1 ul. E. B ... tOO G. P. U. 
Relaxin 
" 
11 2.0 .. 15.1 
1 1If. E. B ... 5 m&:. Prof ... 
• 
100 G. P. U. Relutn 
1 III. E. 8 ... 200 G. P. U. 
.., 207 .. .. 111.3 
Relaxl.n 
" 
l Si.7 .. 26.4 
200 O. P. U. Relaxin 
" 
53.8:;: 12.8 
· Daily Treatment tor 10 day. 
Prog .• Progesterone 
E. B . • Estradiol benzoate 
F • Castrate femaln 
• TABLE GLAND EXTRACTS 
Tnt "bUrial ..... 
Byaluronlda:n° >00 75.5 87.5 95.0 n.1l 88.0 .,., 17.0 
Hyaluronldue· . 00 '1'5.0 88.0' 98.0 !iZ.S 89.0 ".0 78.0 
• lfyaluronldueo ' 00 14.5 88.0 94.5 92.0 8'1.5 .,., 17.0 
HyalllronLdu. · .00 74.5 8$ .Il 98.0 9205 87.5 " .0 78.5 
Hyaluron.ldue· · . 00 74 .0 86.5 97.0 84..0 96.0 87.0 80.0 
Hyll\lronldue' • .00 74.5 S7.0 97.5 .... ~1.0 86.5 7~.$ '.0 
HyalllrOftidu.'* .00 ?S.$ SU n.O ".0 ~0.5 811.0 SO.$ '.0 
!lJalllroaidu.· • '00 74.0 SU n.o U.$ 90.$ 87.0 80.$ '.0 
£xt:I'II,et.1I d., Gtand· ·· '00 72.5 .... 72.$ " .. 72.5 ".0 72.5 0.0 Eldra,et._11 d., Glam' " . 00 12.0 115.11 ?S.O "., ?S .O 72.5 12.5 0.0 
• ~a,et..7 day Gland'" . 00 11.5 112.5 72.0 72.0 72.5 77.5 72.5 '.0 Ii:xtr&e:t·7 day Gland. '. . 00 11.0 82.0 71.5 72.0 72.0 72.0 71.5 
••• Eldraet·8 d., Oland'" .00 72.0 84.S 72.5 72.5 12.0 72.5 ?S.O '.0 
Extract · ; day Oland'" . 00 72.0 82.0 71.0 72.11 71 .0 71.5 71.5 0.' 
Enra,et..l0 day Oland'" ' 00 72.Q 82.5 72.0 ' 71 .5 71. 5 71.5 72.5 0.0 
Eldraet.lO d., .Oland· ·· ' 00 12.0 82.0 71.5 71.5 12.5 72.0 72.0 '.0 
Enra,et.. l1 day Gland' " 
. 00 12.5 84.5 ?S.O 72.5 72.5 73.0 73.0 0.' 
E:rtra,et.·11 day Qt..IId· '· . 00 73.0 85.0 72.5 72.5 72.5 72.0 72.5 0.0 
• ' 3 TIlrbtd1ty Reclucine Ullita/ =l. _. 
-
.5 ml $\Ibabt ... .5 ml Buffer 
**' TIlrbtd1ty Reduclllg UlliUl / =l. n •. 25 ml Sllbatauo .. . 15 =l Buffer 
" ' Day. prtpt.nt 1'IIba m • 
.5 ml Sllbetat ... .5 m1 test material 
1'IIbe IV '. .5 ml !ubt;tat ... .1 m1 BWfer * .4 101 teat MaJ.. 
"' ... V 
-
.5 ml SllbIWe .. 
.2 m1 Buffer ... 3 ml tellt M.t. _n_
.5 Illi Subltate .. 
.3 m1 Buffer ... 2 mllellt Ma t . 
Tuba vn. .5 Illi Substal., .. • 4 ... 1 BlltJer ... 1 ml tn t Mat . 
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uronid2Se were run simultaneously as controls. M ammary .gland exttlas 
from five nortn2.1 rau, three nts pregnant 9 days, eleven cats pregnant 13 
days, and six tats pregnant 17 days, as well as five samples of testicular ex-
tract, were divided into three parts. The first pan of the excncts was heated 
to ~5°C. for 10 minutes. Assays showed that none of the excnctS were in· 
activated by these conditions. The second p:m of the extncts was heated 
co 6O~C. for 10 minutes. Assays showed that the testicular exU:lcrs had lost 
their spreading effect: while the mammary gland extracts were still active. 
Assays of the third parts of the extracts which were heated to 70°C. for 10 
minutes showed that ill were inactivated (Table 15). 
Several studies were made to determine if the spreading factor contained 
some co-factor or if a part of che molecule was held loosely to the remainder. 
One-half of the mammary ghnd extracts from r:m pregnant 10 to 13 days 
were dialyzed for :> hours against a buffer solution. The buffer was changed 
at half·hout intervals. Assays made on the undialyzed, as well as the dia.lyzed 
samples of extraCt showed that as much active spreading factor was present 
in the dialyzed samples as those which were nOt dialyzed (Table 16). These 
investigations indicated that the mammary gland spreading factor is a fairly 
large comput molecule which has no easily separable co-factor. 
TABLE 16--EFFECTS OF HEATING ON THE ACTIVITY OF THE MAMMARY 
GLAND SPREADING FACTOR 
Number 
Type of Extract of 
AnImals 
Testicular 5 
Normal Mammaq 5 
9 day Mammary 3 
13 day Mammary 11 
17 day Mammary 6 
Area of Spread In mm2 and S. D. after 
Heating to 550 C Heating to 600 C Heating to 700 C 
for 10 minutes for 10 mlIlutes for 10 minutes 
S13.3 + 28.4 
44.4 + 12.3 
226.1 + 27.1 
253.3 + 20.7 
100.6 + 12.4 
47.4 + 12.1 
51.6 -; 12.7 
210.1 -; 16.3 
236.4 -; 19.9 
119.3 + 17.6 
51.8 + 12.7 
50.3:; 12.8 
56.4:; 22.4 
49.8 + 28.4 
52.9 + 16.3 
A srudy was also made to determine the effect of high speed centrifuga. 
tion on activity of the mammary gland spreading bctor. Mammary exrncts 
from rats pregnant 10 to 13 days were divided into cwo partS. One puc was 
centrifuged at 25,000 times gravity for 30 minutes. Assays made on the un-
centrifuged, as well as the supernatant of the centrifuged mammary gland 
extracts, showed no difference in amounts of the active spreading baor 
(Table 17). This indicated that the spreading factor is either in true solu-
tion or is on the small particulates of the mammary ghnd cells whicb remain 
suspended in the buffer. 
A final investigation was undertaken to determine if a substance was 
present in the mammary gland during the last half to one·third of pregnancy 
which inactivates the spreading factor during advanced gestation. Assays 
were made on tbe mamm:uy glands of rats pregnant 11, 12 and 13 days; 
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TABLE n·-EFFECTS OF DIALYSIS AND HIGH SPEED CENTRIFUGATION ON 
ACTIVITY OF MAMMARY GLAND SPREADING FACTOR m RATS 
Type of Extract 
10 clay M ammary 
10 day M ammary dlalyud 
10 clay M ammary cenb'Uuied 
13 day M ammary 
13 day M ammary dialyzed 
IS day M ammary centrUl.lged 
Number 
of 
Animal, 
1 
I 
1 
I 
1 
1 
Area of 
Spread mm2 
228.6 
236.4 
221.6 
207.6 
21 7 •• 
229.7 
. then these solutions without the fat were used to extnct the mammary 
glands from ntS pregnant 19 and 20 days. The assays showed that the active 
spreading factor present in mammary gland extracts from the rats at mid-
pregnancy was unaffected by extncting the mammary glands from rats of 
late pregn:lnCY. This indicates that no inactivating substances are present in 
the mammary gland dueing the larrer pact of pregnancy (Table 18). 
TABLE 18··EFFECTS OF MAMMARY GLAND EXTRACTS F ROM RATS m LATE 
PREGNANCY ON SPREADING F ACTOR IN EX TRACTS FROM 
RATS m MID· PREGNANCY 
Type of Extract 
11 clay Mammary 
12 day M ammary 
13 day M alJUllary 
11 day + 19 day M ammary 
12 day + 19 day M ammary 
13 day + 20 day M ammazy 
No. of 
AnImals 
1 
1 
I 
1 
1 
1 
Area of Spread mm2 
22'1 .4 
258.6 
234.9 
236.'1 
25 1,4 
226.3 
Sllmmuy. The mammary gland spreading factor is a heat coaguJabJe 
substance, possibly a protein, fairly stable under normal conditions. It ap-
parently is not the same as the spreading factor hyaluronidase. It has been 
shown that dialysis or high speed centrifugation does nOt change the spread. 
ing activiry of the extract. This indicates th:at the spreading factor is io true 
solution or is attached to the smaller particulates in the mammary gland 
cells which remain suspended in the buffer. It further indicates that the 
spreading faeror is a fairly large molecule which has no easily separable co-
faeror. 
In addition, it was shown that exua.ccs of mammary glands t2ken from 
t2ts in bte pregnancy had no diminishing effect on me spreading facror pres-
ent in extracts of mammary glands taken from nts at mid'pregn:ll0CY, indio 
cating that no :mti-spreading factor is present in the mammary gl:lnd during 
late pregnancy at a time when the spreading factor was shown to I?e very 
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low. In other words, the decline in the amount of spreading factor in the 
latter st2ges of pregnancy is nOt due to the production of a factor which in· 
activates the enyzme. The enzyme is thus [dated to the growth phase of 
mammary gland development and becomes inactive as secretory activity is 
induced. 
DISCUSSION 
The rapid advance of the mammary gland ducts and lobule-alveolar 
system through the connective tissue barrier during pregnancy, Or when cer-
tain hormones are used to induce mammary gland growth, has previously 
been taken for granted. With the discovery of spreading [wors which are 
known to break down the ground substance of the connective tissue, it was 
posrulated that such a spreading factor might be produced by growing cells 
of the advancing mammary gland. 
Inv~stigations on th~ albino rat, albino mous~, guinea pig and rabbit 
hav~ shown that such a spreading factor is pr~scnt in the mammary glands 
of these speci~s during pr~gnancy. It was also noted that the general pat· 
tern of amounts of spreading faeror found in the mammary glands during 
various stages of ptegnancy follows the mammary growth pattern known to 
occur in each of these species. In view of these results, it seems possible that 
a mammary gland spreading faeror is present in all mammalian speci~s and 
that the spreading factor is associated with or involved in mammary gland 
growth into the connectiv~ tissue of the fatty pad. 
A srudy of hormon~s which have been proven to induce both mam-
mary duct and lobule-alveolar growth has revealed that these hormones are 
effective in causing production of the aerive mammary gland spreading fac· 
tor. 
While estrogen and progest~rone. separately, caused elaboration or 
activation of the spreading factor; the correct combination of these two hor· 
mones gave amounts of the spreading factor comparable to those extracted 
from the mammary glands of normal pregnant animals. Prolonged treat· \ 
menr with estrogen and progesterone in the rat caused an increased pro-
duction of the spreading factor for about 1S days, after which the amount 
of spreading factor produced declined despit~ continued treatment. Gradual 
decline of mammary gland growth after a certain period of time, despit~ 
COntinued hormone treatment, has been recognized for some time. The fact 
thac production of che mammary gland spreading factOr follows chis same 
pattern is believed co indicate that only the growing cells of the mammary 
gland elaborate or activate the spr~ading factor. 
The elaboration or activation of greater amounts of the spreading factor 
and the larger size of the mammary gland of castrate rats with previously de· 
veloped duct systems, compared to chose without such syst~ms, strongly 
supportS the hypothesis that the number of c~lls in the mammary gland, 
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especially of growing cells, is related to the production of active spreading 
faCtOr. 
Unfortunately, there is no available method by which the number of 
epithelial cells in the growing mammary gland can be determined. Kirkham 
and Turner (1953 have shown that desoxypentose nucleic acid increases up 
to mid· pregnancy in the rat. This nucleic acid is believed to be a relatively 
conStant constituent of the cell and, therefore, the increase in amount of this 
acid is believed to indicate the multiplication of cells at this time. While 
a quantitative comparison oif the number of epithelial cells in the growing 
mammary gland with the amount of spreading £actor which can be extracted 
cannot be made, the results which have been obtained in chis srudy are be-
lieved to give strong suppOrt to such a theory. 
With furcher increase in our knowledge of the biochemistry of this 
enzyme system and as more quantitative methods of assay are developed, 
the determination of the amount of mammary gland spreading factOr may 
serve both as a method of assay of the hormones involved in the growth of 
the mammary gland and as a quantitative measure of the extent and varia· 
tion in the number of epithelial cells present in the mammary gland, i.e., the 
potential functional capacity of the mammary gland. 
Good elaboration or activation of the mammary gland spreading factOr 
resulted from treatment of castrate female rats with pituitary fractions rich 
in lactogenic hormone. Assays of mammary gland extracts from rats treated 
with pituitary fractions rich in growth hormone, gonadotropic hormone 
(FSH ), thyrotropic hormone and the melanophore factor failed to show the 
presence of the spreading factor. Thus, if as postulated, the presence of the 
spreading factot indicated that mammary gland growth had occurred, these 
data would indicate that the lactogenic fraction of the pituitary is the only 
fraction which possesses mammogenic activity. Due to the possibility that 
more than one substance is present in this pituitary fraction it is possible 
that the mammogenic action is due to a contaminant and nOt the laerogenic 
hormone. 
During the second half of pregnancy, it has been shown, there is a grad-
ual decline in the amount of mammary gland spreading factor. It is at this 
time that the lactogenic hormone is believed to increase, reaching a maxi-
mum follOwing parturition. If the lactogenic hormone were the factor Stim-
ulating growth of the mammary gland one would expect that the spreading 
factor would continue to be present at a high level during the second half of 
pregnancy and early lactation. 
Production of the active spreading factor by a whole pituitary powder 
from rars treated with estrogen and progesterone adds further weight to the 
suggestion that the mammogenic hormone is produced in the anterior pi-
tuitary in response to estrogen and progeSterone administration in experi-
mental animals. 
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Elaboration or acdvation of the mammary gland spreading factor in re-
sponse co treatment with testosterone, cortisone, desoxycorticosterone, the 
diminished effect of estrogen in the absence of the adrenal, and che increased 
effect of estrogen in combination with relaxin also indicate that the spread-
ing factor is associated with or involved in duct and lobule-alveolar growth 
of the mammary gland. 
I n examin ing all data from the animals in normal pregnancy and ani-
mals under various types of hormone treatment, it appears that the spread· 
ing factor is either elaborated or activated in the gtowing mammary gland 
cells by hormones which initiate both duct and lobule-alveolar growth of 
the mammary glands. The spreading factor may then break down the con-
nective tissue in some manner allowing the rapid forward growth of the 
mammary ducts and lobes. 
Heat stability studies of the mammary gland spreading factor show that 
it is inactivated after heating at 70 Q C. for 10 minutes, which suggests the 
possibility that the factor is an enzyme. However, assays reveal that it does 
not act on the substrate hyaluronidase so that it apparently is nor identical 
with the spreading factor hyaluronidase. 
Dialysis and high speed centrifugation of mammary gland spreading 
factor extracts indicated that the spreading factor is either in true solution 
or is associated with the smaller particulates in the mammary epithelial cells. 
Further, the results signify that the spreading factor is a fairly large molecule 
without an easily separable co-factor. 
Extraction of the mammary glands ftom rats in late pregnancy (which 
showed no spreading faeror) with the extract solution of rats in mid-preg-
nancy (which showed large amounts of the spreading factor) failed to dimin-
ish the spreading activity of the latter extracts. Apparently, there is no anti-
spreading factor present in mammary glands of rats during late pregnancy. 
This study indicates that a spreading factor is elaborated or activated 
in the mammary gland during the growth phase of pregnancy. It also has 
been shown that a number of hormones, which are known to induce duct 
and lobule-alveolar growth of the mammary gland, cause elaboration or 
activation of the mammary gland spreading factor. T he theories that the 
amount of spreading factor is related to the numbers of epithelial cells in 
the growing mammary gland and that the spreading factor aids in the for-
ward progress of the mammary gland through the connective tissue barder 
are also presented. 
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SUMMARY 
1. Investigation has revealed the presence of a spreading factor in the 
mammary glands of four species of experimental animals during pregnancy. 
The four species were the albino rat, the albino mouse, the guinea pig and 
the rabbit. The amount of spreading factor present in the glands was found 
to increase during early pregnancy until a peak was reached in from half to 
two-thirds of pregnancy, afrer which it declined until none was present at 
parturition. The spreading facto r was not present in the mammary glands 
of normal or castrate animals of any of the species investigated. The spread-
ing factor was assayed by measuring the extent of intradermal spreading 
achieved when it was injected with T-1824 (Evans Blue) dye into a shaved 
white rabbit. 
2. The injection of a number of hormones, which induce both duct and 
lobule-alveolar growth of the mammary glands, has shown them to be effec-
tive in causing elaboration or activation of the mammary gland spreading 
factor. Estrogen and progesterone, separately or together, pituitary extracts, 
particularly a fraction rich in lactogenic hormone, testosterone, desoxycorti-
costerone acetate, cortisone acetate and relaxin were all shown to be effective 
co a greater or lesser degree in causing or helping to cause elaboration or 
:l.Ctivation of the mammary gland spreading facror. 
3. Prolonged treatment of castrate female rats with the optimum com-
bination of estrogen and progesterone (a ratio of 1:5000) showed that the 
amount of mammary gland spreading facro r increased until a peak was 
reached at 15 days' treatment, after which the amount declined. 
4. Estrogen and progesterone treatment of castrate rats caused the 
elaboration or activation of greater amouncs of the mammary gland spread-
ing factor in the rats with rudimencary duct systems. 
5. Tests revealed that the mammary gland spreading factor did not act 
on the substrate hyaluronic acid and it is probable that this s,preading factor 
is not hyaluronidase. 
6. Investigation showed that the mammary gland spreading factor was 
inactivated by heating to 70°C. for 10 minutes. 
7. Dialysis and high speed centrifugation of mammary gland extracts 
containing large amounts of active spreading aCtivity of the extracts. 
8. Extracting the mammary glands of rats in late pregnancy with the 
extract solutions of mammary glands from rats in mid-pregnancy failed to 
inactivate the spreading factor in the extracts of the glands from the rats in 
mid-pregnancy. 
9. The theory is presented that the amount of spreading factor is re-
lated to the numbers of epithelial cells in the mammary gland. As more 
quantitative methods of assay are developed, it is believed that the deter-
mination of the amount of mammary gland spreading factor may serve both 
as a method of assay of hormones involved in mammary gland growth and 
as a quantitative m~asure ofthe numbers of growing epithelial cells pre-
sent in the mammary gland. 
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